Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016701	p-glu/2h	mmol/l (mmol/l)	1307	1817	0.00%
3016701	p-glukr2h	mmol/l (mmol/l)	1275	1595	0.00%
3016701	p-gluk-2h	mmol/l (mmol/l)	653	896	0.00%
3016701	glukr2h	mmol/l (—)	505	779	100.00%	Distribution not available
3016701	gluk120min	— (—)	332	346	100.00%	Distribution not available
3016701	p-gluk-2t	mmol/l (mmol/l)	315	460	0.00%
3016701	fp-glukoosi(gluk.ras2h)	mmol/l (mmol/l)	214	225	0.00%
3016701	gluk2h	mmol/l (—)	199	280	100.00%	Distribution not available
3016701	p-gluk/2h	mmol/l (mmol/l)	164	180	0.00%
3016701	p-gluk-2h	— (—)	160	260	100.00%	Distribution not available
3016701	fp-gluk-2	mmol/l (mmol/l)	135	168	0.00%
3016701	glukras120	mmol/l (—)	119	153	100.00%	Distribution not available
3016701	glukr-2h	mmol/l (—)	113	144	100.00%	Distribution not available
3016701	p-gluk2h	— (—)	106	125	100.00%	Distribution not available
3016701	fp-gluk-2h	mmol/l (mmol/l)	96	109	0.00%
3016701	glukoosi120min	mmol/l (—)	94	98	100.00%	Distribution not available
3016701	p-gluk2h	mmol/l (mmol/l)	77	90	0.00%
3016701	glukoosikoe,2hnäyte	mmol/l (—)	59	62	100.00%	Distribution not available
3016701	p-glukr2h	— (—)	56	58	100.00%	Distribution not available
3016701	p-gluk-2t	— (—)	54	59	100.00%	Distribution not available
3016701	p-glukoosi2h	mmol/l (mmol/l)	46	53	0.00%
3016701	fp-glukr2h	mmol/l (mmol/l)	42	45	0.00%
3016701	p-gluk-2	mmol/l (mmol/l)	40	56	0.00%
3016701	p-glu/2h	— (—)	34	34	100.00%	Distribution not available
3016701	p-glukgr2	mmol/l (mmol/l)	31	33	0.00%
3016701	p-glukoosi,2h	mmol/l (mmol/l)	25	31	0.00%
3016701	p-gluk(2	mmol/l (mmol/l)	14	18	0.00%
3016701	p-gluk2t	mmol/l (mmol/l)	13	13	0.00%	Distribution not available
3016701	s-glukoosi,2hnäyte	mmol/l (mmol/l)	12	12	0.00%
3016701	s-glukr2h	mmol/l (mmol/l)	11	11	0.00%	Distribution not available
3016701	fp-gluk-2	— (—)	9	9	100.00%	Distribution not available
3016701	p-glukoosi,2hnäyte	mmol/l (mmol/l)	9	9	0.00%	Distribution not available
3016701	p-gluk/2h	— (—)	9	10	100.00%	Distribution not available
3016701	p-gluk(2)	mmol/l (mmol/l)	5	5	0.00%	Distribution not available
3016701	p-gluk-2	— (—)	5	5	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Contact with and exposure to communicable diseases

807

2392

3.48

222.26

1.5

6.47

6.68

mmol/l

1.29

772

1582

Postpartum care and examination

453

479

6.36

216.84

1.6

1.3

6.32

7.07

mmol/l

4.30

387

319

Persons with potential health hazards related to communicable diseases

857

2774

3.15

202.12

1.5

1.4

6.59

6.78

mmol/l

1.13

816

1851

Diabetes mellitus in pregnancy

760

1751

2.90

138.42

1.9

1.3

7.02

6.42

mmol/l

6.10

524

1263

Delivery, wide proxy

448

657

3.70

112.21

1.6

1.2

6.48

7.78

mmol/l

11.90

304

458

Single delivery by caesarean section

344

463

4.42

110.76

1.6

1.2

6.56

7.51

mmol/l

5.14

239

356

Single delivery by forceps and vacuum extractor

287

355

5.08

109.92

1.8

1.2

6.36

7.48

mmol/l

7.28

215

274

Delivery

512

853

3.23

105.68

1.6

1.2

6.47

7.74

mmol/l

14.50

344

619

Other maternal disorders predominantly related to pregnancy

910

2582

2.25

100.16

1.7

1.3

6.95

6.73

mmol/l

1.29

659

1895

Outcome of delivery

348

584

3.80

95.27

1.5

1.3

6.44

7.11

mmol/l

3.15

326

403

Pregnancy, childbirth and the puerperium

370

523

3.77

94.62

1.6

1.2

6.66

7.75

mmol/l

6.57

250

353

Single spontaneous delivery

485

853

3.08

93.11

1.6

1.2

6.51

7.74

mmol/l

12.61

324

619

Maternal care for other known or suspected fetal problems

490

1167

2.76

82.30

1.9

1.4

6.35

6.67

mmol/l

1.71

340

837

Gestational diabetes (for exclusion)

730

2380

2.22

79.27

1.8

1.4

7.11

6.47

mmol/l

6.82

494

1734

Antenatal screening

385

777

2.85

66.15

1.6

1.3

6.28

7.15

mmol/l

6.30

287

546

False labour

516

1415

2.33

61.79

1.7

1.4

6.46

6.78

mmol/l

1.79

359

1030

Maternal care related to the fetus and amniotic cavity and possible delivery problems

655

1910

2.05

56.37

1.6

1.3

6.67

6.95

mmol/l

1.40

459

1406

Other symptoms and signs involving the urinary system

156

394

4.07

55.11

1.3

7.49

7.53

mmol/l

0.04

145

282

Prolonged pregnancy

293

993

2.76

54.13

1.7

1.4

6.22

6.63

mmol/l

1.41

212

716

Abnormal findings on antenatal screening of mother

207

648

3.32

53.32

1.9

1.4

6.37

6.35

mmol/l

0.03

130

473

Non-invasive ventilation

304

1104

2.63

51.96

1.3

6.89

6.41

mmol/l

1.96

187

787

Other obstetric conditions, not elsewhere classified

620

2056

1.99

50.66

1.7

1.5

6.29

6.53

mmol/l

1.67

443

1442

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

609

2020

1.99

49.64

1.7

1.5

6.31

6.52

mmol/l

1.38

441

1414

Type 2 diabetes, definitions combined, including avohilmo

1013

3581

1.69

48.22

1.4

1.3

9.59

6.45

mmol/l

95.86

760

2602

Sleep apnoea, including avohilmo

946

3627

1.70

47.76

1.3

7.56

7.21

mmol/l

2.36

719

2614

Obesity due to excess calories

576

3062

1.90

45.15

1.7

1.4

7.36

6.91

mmol/l

2.85

421

2220

Other nutritional deficiencies

763

4372

1.72

42.81

1.6

1.3

7.38

6.92

mmol/l

3.87

554

3151

Supervision of high-risk pregnancy

301

731

2.53

42.79

1.7

1.3

6.58

7.15

mmol/l

2.57

222

518

Endocrine, nutritional and metabolic diseases

1031

3234

1.63

42.09

1.5

1.3

7.67

6.28

mmol/l

29.02

774

2279

Insulin, intermediate and long-acting

2913

0.20

41.70

1.5

1.3

11.42

7.35

mmol/l

2.32

2094

Obesity

724

4210

1.72

40.56

1.6

1.3

7.39

6.93

mmol/l

3.73

530

3034

Obesity and other hyperalimentation

725

4224

1.71

40.22

1.6

1.3

7.39

6.93

mmol/l

3.77

531

3045

Supervision of normal pregnancy

315

758

2.41

39.97

1.7

1.3

6.09

7.16

mmol/l

9.65

218

533

Sleep apnoea

849

3507

1.65

38.71

1.2

7.58

7.28

mmol/l

1.66

632

2542

Complications of labour and delivery

746

2451

1.71

37.13

1.5

1.4

6.97

6.88

mmol/l

0.30

545

1757

Maternal care for known or suspected abnormality of pelvic organs

376

1263

2.09

35.58

1.7

1.3

6.76

6.86

mmol/l

0.28

267

914

Insulin, combination of fast acting with intermediate-acting or long-acting

109

3176

0.31

35.19

1.8

1.3

9.10

7.30

mmol/l

2.12

2273

Insulin, fast-acting

2063

0.13

34.39

1.1

1.3

12.19

7.23

mmol/l

1.77

1494

Insulin, fast-acting or short human

2059

0.13

34.29

1.1

1.3

12.19

7.22

mmol/l

1.78

1488

Maternal care for other conditions predominantly related to pregnancy

319

1518

2.11

33.31

1.7

1.3

6.75

6.53

mmol/l

0.69

211

1111

Labour and delivery complicated by fetal stress [distress]

401

1378

1.97

32.37

1.7

1.5

6.40

6.51

mmol/l

0.37

286

955

Persons encountering health services in circumstances related to reproduction

576

2253

1.75

32.22

1.4

1.2

6.72

7.32

mmol/l

4.52

422

1663

Insulin medication

109

2806

0.33

31.92

1.8

1.3

9.10

6.66

mmol/l

3.42

2030

Long labour

364

1625

1.99

31.67

1.6

1.4

6.70

6.71

mmol/l

0.01

252

1154

Unknown and unspecified causes of morbidity

114

346

3.38

30.89

1.3

1.4

7.46

7.19

mmol/l

0.34

257

Sleep disorders (combined)

956

4140

1.52

30.75

1.3

7.51

7.09

mmol/l

3.27

718

2979

Acute upper respiratory infections of multiple and unspecified sites

824

3992

1.56

30.02

1.4

6.86

7.01

mmol/l

0.89

656

2819

Episodal and paroxysmal disorders

1202

4242

1.46

30.01

1.3

1.4

7.10

6.98

mmol/l

0.68

896

2985

Polyhydramnios

284

3.58

28.76

1.8

1.4

6.65

7.08

mmol/l

0.88

205

Maternal care for known or suspected malpresentation of fetus

282

1015

2.11

27.94

1.7

1.4

6.17

6.67

mmol/l

2.95

193

735

Continuous positive airway pressure

189

685

2.41

26.85

1.3

1.2

7.64

6.56

mmol/l

4.49

157

503

Sub-endpoint used in defining T1D endpoints

1651

0.15

26.83

1.4

1.3

11.51

7.13

mmol/l

1.60

1198

Type 2 diabetes, definitions combined

912

3668

1.49

26.31

1.4

1.3

9.73

6.55

mmol/l

81.96

674

2676

Type 2 diabetes, strict (exclude DM1)

911

3676

1.49

25.92

1.4

1.3

9.73

6.55

mmol/l

81.94

673

2683

Other special examinations and investigations of persons without complaint or reported diagnosis

778

2567

1.54

25.37

1.3

7.20

6.97

mmol/l

1.14

550

1832

Pregnancy examination and test

200

536

2.36

25.15

1.6

1.3

6.52

7.02

mmol/l

1.43

142

356

Gestational [pregnancy-induced] hypertension

376

2125

1.79

24.42

1.6

1.5

6.96

6.73

mmol/l

0.77

263

1535

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

575

3175

1.60

24.14

1.6

1.4

6.94

6.83

mmol/l

0.39

422

2303

Hypertension, essential

726

2709

1.54

24.00

1.2

7.85

7.06

mmol/l

6.40

566

1999

Obstructed labour due to malposition and malpresentation of fetus

319

1629

1.87

23.73

1.6

1.4

6.64

6.71

mmol/l

0.17

238

1167

Premature rupture of membranes

297

1141

1.94

23.59

1.6

1.4

6.41

6.70

mmol/l

1.19

185

815

Additional codes for the location of defect, injury or illness

237

3.47

22.68

1.4

1.3

6.70

7.34

mmol/l

1.02

164

Acute upper respiratory infections

1015

4518

1.41

22.45

1.4

1.3

7.06

7.08

mmol/l

0.09

762

3181

Hypertension

743

2805

1.51

22.38

1.2

7.85

7.04

mmol/l

7.09

577

2063

Hypertensive diseases

743

2808

1.50

22.29

1.2

7.85

7.04

mmol/l

7.08

577

2064

Type 1 diabetes

1487

0.19

22.05

1.4

1.3

11.58

6.42

mmol/l

2.02

1089

Perineal laceration during delivery

262

1241

1.91

20.68

1.6

1.5

6.14

6.48

mmol/l

1.69

176

848

Dental caries 1 and operation codes

786

2760

1.47

20.48

1.3

7.32

7.22

mmol/l

0.32

547

2059

Hypertensive diseases (excluding secondary)

562

2109

1.56

19.91

1.2

1.3

7.92

6.95

mmol/l

7.25

436

1529

Dental caries 3, only avohilmo

759

2656

1.47

19.83

1.3

7.37

7.14

mmol/l

0.84

529

1990

Pregnancy hypertension

523

3060

1.55

19.66

1.5

1.4

6.88

6.82

mmol/l

0.15

383

2216

Neurological diseases

978

3550

1.39

19.17

1.4

7.03

6.92

mmol/l

0.49

716

2496

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1077

4516

1.36

19.14

1.4

1.3

7.27

7.02

mmol/l

1.78

879

3097

Diabetic retinopathy, excluding more controls

962

0.28

19.09

1.2

1.4

9.95

9.62

mmol/l

0.23

700

Bronchitis

1029

4959

1.37

18.87

1.4

1.3

6.99

7.05

mmol/l

0.31

810

3468

Dental caries 3 and operation codes

822

2967

1.43

18.60

1.3

7.30

7.17

mmol/l

0.40

571

2218

General examination and investigation of persons without complaint and reported diagnosis

704

2567

1.47

18.53

1.4

1.3

7.18

6.97

mmol/l

0.96

563

1832

Dental caries 3

741

2627

1.45

18.12

1.3

7.31

7.14

mmol/l

0.59

517

1969

Other disorders of amniotic fluid and membranes

189

940

2.02

18.01

1.7

1.4

6.59

6.67

mmol/l

0.16

133

678

Presence of other devices

166

800

2.09

17.57

1.3

1.2

8.30

7.58

mmol/l

1.48

126

547

Parasetamol

904

3345

1.39

17.27

1.3

1.4

7.02

6.93

mmol/l

0.40

658

2362

Persons encountering health services in other circumstances, wide

1156

4526

1.33

17.11

1.4

1.3

7.27

7.02

mmol/l

1.74

943

3103

Dental caries 1, only avohilmo

685

2426

1.45

16.92

1.3

7.38

7.18

mmol/l

0.64

481

1812

Type 2 diabetes

905

3934

1.37

16.78

1.4

1.3

9.76

6.52

mmol/l

82.23

668

2858

Dental caries 1

674

2395

1.44

16.34

1.3

7.35

7.17

mmol/l

0.54

473

1790

Dental caries, including avohilmo

673

2394

1.44

16.25

1.3

7.34

7.17

mmol/l

0.53

472

1789

Statin medication

631

2452

1.45

15.90

1.2

1.3

7.87

6.88

mmol/l

9.28

504

1744

Dental operations, only avohilmo

577

2009

1.48

15.75

1.3

1.2

7.38

mmol/l

0.01

422

1520

Postpartum haemorrhage

317

1696

1.64

15.12

1.6

1.4

6.34

6.68

mmol/l

1.87

220

1208

Symptoms and signs involving the circulatory and respiratory systems

1090

4164

1.32

15.04

1.3

1.4

7.12

6.94

mmol/l

1.05

801

2965

Diabetic retinopathy

1087

0.37

14.97

1.2

1.3

10.27

9.69

mmol/l

0.52

790

Dental operations

531

1876

1.46

13.68

1.3

1.2

7.36

7.38

mmol/l

0.05

381

1433

Headache

678

4153

1.37

13.37

1.4

7.10

6.98

mmol/l

0.44

514

2928

Other (not insulin) diabetes medications

840

3813

1.33

13.15

1.4

1.3

9.78

6.63

mmol/l

71.28

607

2790

Dental pulpitis 2, only avohilmo

594

2159

1.41

12.96

1.3

7.26

7.20

mmol/l

0.14

415

1620

Disorders of lipoprotein metabolism and other lipidaemias

615

2782

1.39

12.95

1.3

1.2

7.67

7.39

mmol/l

1.11

462

2028

Dental pulpitis 2

585

2130

1.41

12.69

1.3

7.29

7.19

mmol/l

0.28

409

1597

Care involving use of rehabilitation procedures

531

3604

1.40

12.43

1.3

7.34

7.20

mmol/l

0.47

386

2595

Dorsopathies

1041

4154

1.28

12.02

1.4

7.09

6.98

mmol/l

0.54

773

2924

Failed induction of labour

439

2.24

11.97

2.0

1.5

6.64

6.70

mmol/l

0.08

306

Other dorsopathies, not elsewhere classified

1007

4146

1.29

11.88

1.4

7.08

6.98

mmol/l

0.45

753

2921

Soft tissue disorders

1029

4186

1.28

11.78

1.3

1.4

6.93

6.99

mmol/l

0.22

770

2936

Biguanides

794

3723

1.32

11.67

1.4

1.3

9.79

6.66

mmol/l

67.94

568

2724

Other abnormal products of conception

441

2054

1.44

11.26

1.6

1.4

6.47

6.67

mmol/l

0.85

305

1482

Haemorrhage in early pregnancy

281

1774

1.56

11.11

1.5

1.3

6.96

6.70

mmol/l

0.70

209

1308

Dental pulpitis 4, only avohilmo

1043

4312

1.27

10.96

1.4

1.3

7.12

7.02

mmol/l

0.38

715

3105

Spontaneous abortion

506

2479

1.40

10.92

1.5

1.4

6.91

6.84

mmol/l

0.19

364

1785

Dental pulpitis 1, only avohilmo

1044

4320

1.27

10.91

1.4

1.3

7.11

7.02

mmol/l

0.37

715

3112

Glucagon-like peptide-1 (GLP-1) analogues

128

1936

0.54

10.90

1.2

11.68

6.89

mmol/l

12.95

1401

1047

4389

1.26

10.81

1.4

1.3

7.14

7.06

mmol/l

0.36

796

3066

Diabetes, varying definitions

914

4283

1.28

10.68

1.4

1.3

9.68

6.49

mmol/l

79.58

676

3095

Obesity related asthma

276

1802

1.54

10.53

1.3

7.57

7.30

mmol/l

0.72

194

1310

Other soft tissue disorders, not elsewhere classified

860

4159

1.28

10.28

1.4

7.02

6.98

mmol/l

0.13

636

2921

Diabetes mellitus

918

4321

1.27

10.26

1.4

1.3

9.71

6.47

mmol/l

78.84

680

3123

Diseases of pulp and periapical tissues, including avohilmo

1019

4220

1.26

10.15

1.4

1.3

7.10

7.01

mmol/l

0.36

706

3039

Procreative management

251

1357

1.57

10.14

1.5

1.2

7.07

7.26

mmol/l

0.40

180

995

Dental pulpitis 1

1019

4227

1.26

10.03

1.4

1.3

7.10

7.01

mmol/l

0.36

705

3045

Lumbar disc prolapse

534

3139

1.36

10.01

1.3

7.30

7.24

mmol/l

0.15

394

2265

Dental pulpitis 4

1018

4226

1.25

9.94

1.4

1.3

7.10

7.01

mmol/l

0.36

705

3044

Fitting and adjustment of other devices

211

1220

1.62

9.86

1.3

1.2

7.94

7.72

mmol/l

0.39

142

853

Pure hypercholesterolaemia

496

2430

1.37

9.82

1.2

7.52

7.45

mmol/l

0.16

378

1761

Other sleep disorders

102

515

2.00

9.80

1.4

1.3

7.06

7.20

mmol/l

0.17

379

Maternal care for known or suspected disproportion

228

2.55

9.66

1.3

6.60

7.19

mmol/l

0.88

179

Dorsalgia

958

4138

1.26

9.63

1.4

7.11

6.97

mmol/l

0.67

710

2915

Multiple delivery

344

2.21

9.31

1.4

1.2

6.81

7.81

mmol/l

2.17

261

Type of accident

242

1580

1.54

9.31

1.4

1.3

7.14

7.17

mmol/l

0.03

192

1135

Antepartum haemorrhage, not elsewhere classified

107

561

1.93

9.28

1.8

1.3

6.63

6.84

mmol/l

0.31

412

Provisional assignment of new diseases of uncertain etiology

417

3023

1.39

9.23

1.3

1.4

6.91

6.97

mmol/l

0.13

249

2188

Codes for special purposes

417

3024

1.39

9.21

1.3

1.4

6.91

6.97

mmol/l

0.13

249

2189

Hyperlipidaemia, other/unspecified

228

1395

1.55

9.07

1.3

1.2

8.26

7.66

mmol/l

1.45

159

988

Carpal tunnel syndrome

474

3168

1.36

9.05

1.4

1.3

7.29

7.31

mmol/l

0.04

348

2314

Other and unspecified nerve root and plexus disorders, also in other diseases

167

1007

1.67

8.99

1.3

6.92

7.32

mmol/l

0.88

109

759

Other specified/unspecified hearing loss

261

2.36

8.92

1.3

8.56

7.47

mmol/l

1.25

188

Any event in cancer register

554

4315

0.76

8.92

1.2

1.3

7.32

7.08

mmol/l

0.91

436

3081

Contraceptive management

359

1789

1.42

8.65

1.3

1.2

6.98

7.26

mmol/l

0.95

276

1323

Flat foot [pes planus] (acquired)

430

2.02

8.56

1.3

7.14

7.33

mmol/l

0.25

324

Exposure to unspecified factor

548

5536

0.77

8.52

1.3

7.12

7.04

mmol/l

0.29

417

3935

Combinations of oral blood glucose lowering drugs

1221

0.45

8.49

1.1

1.2

11.27

6.96

mmol/l

4.23

885

Other intervertebral disc disorders

716

3441

1.28

8.47

1.3

7.23

7.16

mmol/l

0.22

522

2461

Other retinal disorders

195

2421

0.64

8.42

1.2

1.3

7.60

7.46

mmol/l

0.24

137

1723

983

0.39

8.37

1.4

1.6

6.71

6.63

mmol/l

0.12

696

Pregnancy with abortive outcome

684

2794

1.29

8.24

1.5

1.4

6.79

6.84

mmol/l

0.15

482

1979

Persons encountering health services for examination and investigation

659

2567

1.29

8.18

1.3

7.06

6.97

mmol/l

0.29

467

1832

Leisure time condition

151

914

1.66

8.07

1.4

7.13

7.16

mmol/l

0.02

117

658

Angina pectoris

367

1790

1.39

7.91

1.3

1.2

7.75

7.63

mmol/l

0.27

258

1294

Covid-19 confirmed case

233

1566

1.50

7.89

1.4

6.71

7.10

mmol/l

1.28

201

1126

Autoimmune diseases excluding thyroid diseases

660

4627

0.79

7.78

1.4

1.3

7.28

6.96

mmol/l

1.47

474

3302

Artrosis, including avohilmo

681

2943

1.27

7.74

1.2

1.3

7.23

7.30

mmol/l

0.24

507

2135

Twin gestation

101

556

1.84

7.61

1.5

1.3

6.39

6.85

mmol/l

1.03

408

Diseases of oral cavity, salivary glands and jaws

805

3325

1.24

7.50

1.3

7.13

7.12

mmol/l

0.03

585

2385

Rheumatism, unspecified

111

632

1.77

7.45

1.3

1.2

7.22

7.55

mmol/l

0.48

467

Rotator cuff syndrome

442

2473

1.33

7.42

1.2

7.50

7.46

mmol/l

0.08

333

1771

Pain (limb, back, neck, head abdominally)

707

2817

1.26

7.33

1.3

7.24

7.09

mmol/l

0.50

498

1987

Speech therapy

193

1274

1.52

7.18

1.2

1.3

7.34

7.48

mmol/l

0.27

138

931

Multiple gestation

102

574

1.80

7.17

1.5

1.3

6.39

6.89

mmol/l

1.16

422

Spondylolisthesis/Spondylolysis

138

844

1.65

7.13

1.3

1.2

7.04

7.46

mmol/l

0.71

105

622

Septicaemia

110

1784

0.59

7.10

1.2

1.3

7.22

7.43

mmol/l

0.35

1234

Migraine with aura

253

1767

1.44

7.10

1.4

1.5

6.79

6.76

mmol/l

0.06

190

1255

Other blood glucose lowering drugs, excl. Insulins

608

0.29

7.08

1.2

8.63

6.97

mmol/l

0.60

440

Retained placenta and membranes, without haemorrhage

120

711

1.70

7.04

1.5

1.3

7.16

7.07

mmol/l

0.09

510

Placenta praevia

272

2.17

6.96

1.8

1.4

6.06

7.25

mmol/l

3.02

198

Cholecystectomy

513

3532

1.29

6.95

1.3

7.67

7.25

mmol/l

1.95

353

2561

Diseases of the respiratory system

640

2539

1.27

6.92

1.3

7.25

6.99

mmol/l

1.03

470

1754

Asthma, including avohilmo

1041

5058

1.20

6.86

1.4

1.3

7.15

7.02

mmol/l

0.64

758

3604

Obesity, other/unspecified

307

2231

1.38

6.86

1.4

1.3

7.42

6.92

mmol/l

2.13

231

1647

Other septicaemia

1603

0.57

6.83

1.2

1.3

7.22

7.45

mmol/l

0.35

1117

126

2.76

6.82

1.3

6.87

7.59

mmol/l

0.49

Autoimmune diseases excluding thyroid diseases, strict definition

655

4540

0.80

6.82

1.4

7.26

6.96

mmol/l

1.43

471

3240

Supplementary factors related to causes of morbidity and mortality classified elsewhere

251

1765

1.43

6.80

1.4

1.3

7.11

7.14

mmol/l

0.03

198

1273

Preterm labour and delivery

229

1585

1.45

6.76

1.4

1.3

7.21

6.96

mmol/l

0.57

177

1167

Other pulmonary diagnosis

804

3282

1.23

6.74

1.3

7.35

7.02

mmol/l

1.70

607

2283

Heart failure and bmi 25plus

1039

0.55

6.72

1.2

8.68

7.70

mmol/l

1.46

675

Pre-eclampsia or poor fetal growth

352

2617

1.35

6.72

1.6

1.5

6.42

6.74

mmol/l

1.76

266

1880

Transient ischemic attack

293

1749

1.39

6.71

1.2

7.19

7.72

mmol/l

1.89

222

1229

Maternal care for known or suspected fetal abnormality and damage

174

1013

1.54

6.69

1.7

1.4

6.16

6.71

mmol/l

2.44

116

735

COPD differential diagnosis

801

3272

1.23

6.67

1.3

7.36

7.02

mmol/l

1.79

602

2277

ILD differential diagnosis

800

3270

1.23

6.62

1.3

7.36

7.02

mmol/l

1.82

601

2276

Metabolic disorders

730

3680

1.23

6.62

1.3

7.58

7.20

mmol/l

2.36

545

2665

Antihypertensive medication - note that there are other indications

683

3006

1.25

6.59

1.4

1.5

7.15

6.41

mmol/l

8.09

504

2121

Migraine

499

3320

1.28

6.55

1.4

1.5

6.69

6.77

mmol/l

0.28

379

2347

Asthma (mode)

733

3270

1.23

6.47

1.4

1.3

7.23

7.02

mmol/l

0.90

535

2276

Persons encountering health services in other circumstances

320

2362

1.36

6.47

1.4

7.06

6.93

mmol/l

0.29

259

1602

COPD/asthma related infections

978

4089

1.20

6.43

1.4

1.3

7.24

7.02

mmol/l

1.25

738

2861

COPD/asthma/ILD related infections

978

4089

1.20

6.43

1.4

1.3

7.24

7.02

mmol/l

1.25

738

2861

Asthma, excluding more controls

736

3189

1.23

6.42

1.4

1.3

7.24

7.00

mmol/l

1.10

536

2221

Functional dyspepsia

215

1488

1.45

6.38

1.3

7.09

7.33

mmol/l

0.52

167

1078

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

529

1.78

6.38

1.5

1.4

7.04

7.03

mmol/l

0.02

387

Pneumonias (Asthma/COPD co-morbidities)

591

5085

0.80

6.27

1.3

7.34

7.03

mmol/l

1.53

432

3639

Excluding asthma or asthma-COPD overlap

798

3282

1.22

6.26

1.3

7.36

7.02

mmol/l

1.78

600

2283

Exclusions for E4_PCOS_CONSORTIUM

469

3751

0.78

6.25

1.3

1.4

7.16

6.89

mmol/l

1.15

342

2714

Any operation in hilmo

113

2.32

6.23

1.5

1.1

7.19

7.27

mmol/l

0.05

Spondylosis

346

2225

1.34

6.21

1.3

1.2

7.27

7.51

mmol/l

0.66

270

1617

Complications predominantly related to the puerperium

291

2135

1.37

6.21

1.6

1.5

6.74

6.78

mmol/l

0.08

211

1531

Other diseases of hard tissues of teeth

549

3256

1.26

6.18

1.3

6.86

7.09

mmol/l

1.13

412

2343

Fall on same level

780

5262

0.83

6.11

1.3

7.22

7.00

mmol/l

1.09

574

3747

Disorders of choroid and retina

323

3131

0.75

6.05

1.2

1.3

7.54

7.40

mmol/l

0.30

220

2250

Factors influencing health status and contact with health services

258

916

1.42

6.04

1.3

1.2

7.09

7.31

mmol/l

0.46

197

630

Asthma

739

3253

1.22

5.93

1.4

1.3

7.24

7.02

mmol/l

0.95

537

2263

Shoulder lesions

574

2816

1.25

5.90

1.2

7.50

7.36

mmol/l

0.39

417

2014

Malignant neoplasm

491

3672

0.79

5.89

1.2

1.3

7.35

7.25

mmol/l

0.30

383

2651

Pain in joint

527

2779

1.26

5.79

1.4

1.3

7.05

7.07

mmol/l

0.05

396

1965

All pneumoniae

602

5103

0.81

5.79

1.3

7.32

7.03

mmol/l

1.36

441

3652

Pain in throat and chest

737

3714

1.22

5.79

1.2

1.3

7.19

7.03

mmol/l

0.63

551

2662

Diseases of arteries, arterioles and capillaries

228

2364

0.72

5.71

1.2

7.74

7.52

mmol/l

0.45

166

1682

Influenza and pneumonia

664

5290

0.82

5.56

1.3

7.27

7.00

mmol/l

1.35

491

3771

Nerve, nerve root and plexus disorders

864

4566

1.19

5.51

1.4

1.3

7.23

7.13

mmol/l

0.42

623

3285

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

508

3736

0.80

5.45

1.2

1.3

7.36

7.20

mmol/l

0.54

395

2697

Gonarthrosis

476

2161

1.27

5.42

1.2

7.23

7.38

mmol/l

0.44

351

1587

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

509

3738

0.80

5.40

1.2

1.3

7.38

7.19

mmol/l

0.63

396

2698

Malignant neoplasm, wide definition for exclusion

509

3738

0.80

5.40

1.2

1.3

7.38

7.19

mmol/l

0.63

396

2698

Deforming dorsopathies

220

1581

1.40

5.37

1.3

7.17

7.19

mmol/l

0.03

164

1127

Gastro-oesophageal reflux disease

497

3533

1.25

5.36

1.3

7.00

7.28

mmol/l

1.19

355

2545

Asthma mixed form (mode)

246

2.05

5.36

1.3

1.4

7.04

7.08

mmol/l

0.03

168

Mouth breathing

289

2170

1.34

5.31

1.2

7.05

7.34

mmol/l

0.86

220

1586

Asthma mixed form (mode), excluding more controls

247

2.04

5.30

1.3

1.4

7.04

7.06

mmol/l

0.01

167

Renal tubulo-interstitial diseases

469

4483

0.80

5.30

1.3

1.4

7.45

7.07

mmol/l

1.78

341

3195

Other bacterial diseases

486

4175

0.80

5.27

1.2

1.3

7.84

7.16

mmol/l

4.17

365

3016

Cholelithiasis

629

3626

1.22

5.25

1.3

7.74

7.16

mmol/l

3.83

438

2636

General symptoms and signs

1041

4473

1.17

5.13

1.4

1.3

7.15

7.03

mmol/l

0.59

764

3156

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

190

1743

0.71

5.09

1.2

1.3

7.31

mmol/l

0.01

151

1280

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

190

1743

0.71

5.09

1.2

1.3

7.31

mmol/l

0.01

151

1280

Lyme disease

1267

0.59

5.05

1.2

1.3

6.74

7.42

mmol/l

1.15

936

Asthma (only as main-diagnosis), excluding more controls

648

3189

1.21

5.04

1.4

1.3

7.10

7.00

mmol/l

0.30

463

2221

Postpartum hemorraghe, all women as controls

317

2432

1.31

4.94

1.6

1.5

6.34

6.62

mmol/l

1.51

220

1755

Cholelithiasis, broad definition with cholecystitis

651

3706

1.21

4.90

1.3

7.70

7.16

mmol/l

3.51

453

2694

Diabetes medication

852

4399

1.18

4.89

1.4

1.3

9.78

6.56

mmol/l

71.68

622

3187

Cardiovascular diseases

702

3190

1.20

4.89

1.4

6.92

6.62

mmol/l

1.85

533

2227

Examination and encounter for administrative purposes

143

2.33

4.86

1.3

10.08

7.34

mmol/l

—

Other diseases of pleura

117

1570

0.66

4.85

1.2

8.05

7.67

mmol/l

0.61

1112

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

580

4925

0.83

4.83

1.3

7.40

7.06

mmol/l

1.65

422

3537

Benzodiazepine use

615

5257

0.83

4.81

1.3

7.57

7.01

mmol/l

3.88

458

3754

Asthma (only as main-diagnosis)

649

3253

1.21

4.80

1.4

1.3

7.10

7.02

mmol/l

0.23

464

2263

Hypothyroidism (congenital or acquired)

354

1580

1.29

4.78

1.4

1.5

7.11

6.17

mmol/l

5.53

253

1097

Gonarthrosis [arthrosis of knee](FG)

545

2624

1.22

4.71

1.2

7.15

7.39

mmol/l

0.94

395

1924

Arthrosis

555

2498

1.22

4.70

1.2

7.30

mmol/l

0.02

411

1830

Spondylopathies

565

2820

1.22

4.68

1.3

7.40

7.35

mmol/l

0.12

424

2030

Pain in limb

650

3927

1.20

4.67

1.4

7.00

7.02

mmol/l

0.06

486

2764

Other obstructed labour

449

1.71

4.67

1.4

1.3

7.69

7.11

mmol/l

0.71

320

Disease of hard tissues of teeth, NOS

3.43

4.65

1.2

1.3

7.11

7.25

mmol/l

0.07

Explicit Sepsis

147

2023

0.69

4.65

1.4

1.3

6.99

7.33

mmol/l

0.85

103

1411

Hypothyroidism and >3 levothyroxin purchases

352

1578

1.29

4.65

1.4

1.5

7.12

6.17

mmol/l

5.54

252

1096

Hypothyroidism, levothyroxine purchases

352

1578

1.29

4.65

1.4

1.5

7.12

6.17

mmol/l

5.54

252

1096

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

555

4805

0.83

4.63

1.3

7.18

7.14

mmol/l

0.12

406

3465

Pilonidal cyst

503

1.66

4.63

1.4

6.99

6.84

mmol/l

0.19

374

COPD, hospital admissions 3, with asthma pneumonia sepsis

740

0.53

4.62

1.3

1.2

8.46

7.91

mmol/l

0.39

513

Other spirochaetal diseases

1286

0.61

4.62

1.2

1.3

6.71

7.42

mmol/l

1.29

947

Gonarthrosis,primary

570

2956

1.21

4.60

1.2

7.24

7.52

mmol/l

1.19

419

2156

Other symptoms and signs involving the circulatory and respiratory systems

268

1.92

4.59

1.7

1.4

7.41

7.24

mmol/l

0.14

197

Disorders of the thyroid gland

829

4624

1.17

4.59

1.3

1.4

7.25

6.97

mmol/l

1.44

604

3283

Brachial plexus disorders

559

1.62

4.56

1.3

7.67

7.10

mmol/l

0.95

423

Neurological diseases, wide definition

364

1430

1.28

4.53

1.4

1.5

6.87

6.19

mmol/l

3.98

256

971

Other diseases of upper respiratory tract

953

4282

1.16

4.50

1.3

7.12

7.08

mmol/l

0.12

696

3050

Chronic diseases of tonsils and adenoids

739

3962

1.18

4.48

1.4

6.83

7.00

mmol/l

0.81

539

2852

Other hearing loss

138

929

1.46

4.45

1.3

1.2

8.40

7.63

mmol/l

1.43

107

651

Spinal stenosis

277

1660

1.31

4.43

1.2

7.79

7.68

mmol/l

0.20

199

1188

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

401

2032

1.25

4.40

1.3

7.16

6.95

mmol/l

0.65

312

1464

Triptan medication for migraine, single purchase ok

736

4232

1.18

4.37

1.4

6.83

6.95

mmol/l

0.46

544

3068

Migraine, single triptan purchase ok & required. ICD-code if available is included

736

4232

1.18

4.37

1.4

6.83

6.95

mmol/l

0.46

544

3068

Examination and observation for other reasons

331

2555

0.79

4.37

1.3

6.90

6.97

mmol/l

0.16

222

1821

Poor fetal growth

170

1218

1.41

4.37

1.7

1.5

6.13

6.67

mmol/l

2.53

125

875

Other arthrosis

357

2019

1.27

4.36

1.2

7.17

7.42

mmol/l

0.78

270

1481

Other noninflammatory disorders of cervix uteri

184

2.09

4.32

1.3

7.20

7.51

mmol/l

0.22

132

Abnormalities of breathing

817

4156

1.17

4.32

1.3

1.4

7.21

6.94

mmol/l

1.65

593

2959

Malignant neoplasm of breast

197

1924

0.74

4.30

1.2

7.41

7.39

mmol/l

0.03

156

1417

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

128

1450

0.69

4.30

1.2

7.61

7.60

mmol/l

0.01

105

1021

Familial hypercholesterolemia

498

1.63

4.28

1.2

7.66

7.78

mmol/l

0.12

350

Sequelae of cerebrovascular disease

1152

0.63

4.27

1.3

1.2

7.18

7.81

mmol/l

0.72

801

Iron deficiency

134

2.29

4.20

1.6

1.5

6.85

6.64

mmol/l

0.09

Primary gonarthrosis, bilateral

271

1828

1.30

4.17

1.2

7.43

7.69

mmol/l

0.76

202

1308

Renal failure

113

1522

0.68

4.16

1.2

8.52

7.63

mmol/l

1.91

1057

Cough

289

2161

1.29

4.15

1.3

6.76

7.18

mmol/l

1.73

207

1549

Any dementia, excluding more controls

727

0.59

4.14

1.3

1.2

7.48

7.94

mmol/l

0.63

475

Malignant neoplasm of breast, HER2-negative

188

1871

0.74

4.14

1.2

7.45

7.41

mmol/l

0.05

150

1373

Exposure to other specified factors

431

4928

0.82

4.13

1.3

1.4

7.06

7.04

mmol/l

0.06

330

3518

Varus deformity, not elsewhere classified

3.16

4.13

1.4

7.20

7.23

mmol/l

0.01

Degenerative diseases of the nervous system

690

0.57

4.11

1.3

1.2

7.59

8.04

mmol/l

0.47

455

Any dementia

745

0.59

4.11

1.3

1.2

7.49

8.01

mmol/l

0.76

487

Fibromyalgia

498

1.62

4.07

1.4

6.93

7.25

mmol/l

0.43

357

Low back pain

616

4003

1.19

4.06

1.4

7.03

7.00

mmol/l

0.09

455

2823

Other assisted single delivery

2.81

4.05

1.6

1.3

6.81

7.98

mmol/l

—

L04AA Selective immunosuppressants

1194

0.63

4.05

1.3

7.23

7.22

mmol/l

0.01

891

Presence of other functional implants

181

1740

0.73

4.04

1.2

7.85

7.56

mmol/l

0.53

126

1223

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

326

4012

0.80

4.04

1.4

6.66

6.96

mmol/l

1.19

238

2908

Bacterial Sepsis

141

1764

0.71

4.01

1.2

8.02

7.53

mmol/l

0.77

102

1220

COPD, hospital admission 2, with asthma infections

977

0.62

4.01

1.4

1.2

7.92

7.84

mmol/l

0.07

684

Other enthesopathies

222

1683

1.32

3.97

1.3

7.51

7.36

mmol/l

0.28

159

1230

Cardiovascular diseases (excluding rheumatic etc)

676

3317

1.18

3.95

1.3

1.4

7.22

6.67

mmol/l

3.98

517

2352

Other degenerative diseases of the nervous system

951

0.64

3.95

1.4

1.3

6.79

7.50

mmol/l

1.24

644

Acute nasopharyngitis (common cold)

102

673

1.52

3.92

1.2

1.3

6.72

7.19

mmol/l

0.82

496

Disorders of synovium and tendon

421

3105

1.22

3.92

1.3

7.05

7.17

mmol/l

0.35

322

2207

Abdominal and pelvic pain

910

3973

1.15

3.91

1.4

1.3

7.26

7.07

mmol/l

0.86

636

2831

Disorders of muscles

442

1.64

3.88

1.4

1.3

6.77

7.34

mmol/l

0.77

317

Other specified/unspecified soft tissue disorders

179

2.03

3.85

1.4

1.3

7.43

7.62

mmol/l

0.12

126

Senile cataract

247

1979

0.77

3.83

1.2

7.87

7.57

mmol/l

0.70

178

1442

Ischaemic heart disease, wide definition

475

2457

1.21

3.83

1.2

7.57

7.49

mmol/l

0.22

357

1787

Pneumonia, organism unspecified

523

4503

0.84

3.81

1.3

7.56

7.12

mmol/l

2.11

385

3223

Acute tubulo-interstitial nephritis

312

3458

0.80

3.80

1.3

1.4

7.23

7.09

mmol/l

0.36

226

2441

ILD medications: prednisolone, methylprednisolone, prednisone

761

4975

0.86

3.77

1.3

7.23

7.01

mmol/l

1.13

569

3541

Other female pelvic inflammatory diseases

138

981

1.41

3.75

1.3

1.4

7.07

7.21

mmol/l

0.25

103

709

First line medication for Crohn's disease

800

5030

0.87

3.75

1.3

1.4

7.16

7.00

mmol/l

0.76

590

3566

Substance abuse, excluding more controls

298

3267

0.80

3.72

1.3

7.47

7.05

mmol/l

1.28

222

2346

Other appendicitis

394

1.66

3.70

1.3

6.64

7.14

mmol/l

0.63

290

Allergic conjunctivitis

346

4186

0.81

3.66

1.4

6.66

6.96

mmol/l

1.18

252

3022

Disorders of lens

293

2324

0.79

3.66

1.2

7.71

7.55

mmol/l

0.34

211

1701

Polycystic ovarian syndrome, broad definition

159

1165

1.38

3.65

1.8

1.6

6.78

6.50

mmol/l

0.62

101

817

Ischemic heart diseases

485

2531

1.20

3.62

1.2

7.58

7.46

mmol/l

0.36

366

1837

Family history of other specific disorders

2.71

3.60

2.2

1.5

6.33

6.83

mmol/l

0.43

Lower back pain or/and sciatica

855

5183

1.15

3.58

1.3

7.11

7.04

mmol/l

0.28

637

3683

Extracorporeal dialysis

195

0.25

3.53

1.2

1.3

7.92

7.31

mmol/l

—

145

Fracture of femur

763

0.58

3.53

1.3

1.2

8.11

7.76

mmol/l

0.37

520

Gingivitis and periodontal diseases

745

3323

1.16

3.51

1.3

7.32

7.12

mmol/l

0.82

540

2384

ILD medications: immunosuppressive drugs

349

4091

0.82

3.51

1.4

1.3

7.15

7.11

mmol/l

0.08

256

2931

Pre-eclampsia or eclampsia

204

1560

1.31

3.50

1.4

6.61

6.93

mmol/l

1.11

159

1153

Dental caries 2 and operation codes

677

4638

1.16

3.50

1.4

6.68

7.00

mmol/l

2.20

512

3315

Diseases of the musculoskeletal system and connective tissue

586

2494

1.18

3.47

1.4

6.75

6.85

mmol/l

0.34

435

1718

Atherosclerosis, excluding cerebral and coronary sclerosis

1152

0.69

3.46

1.3

1.2

7.82

7.94

mmol/l

0.13

782

Pre-eclampsia

195

1485

1.32

3.45

1.4

6.65

6.90

mmol/l

0.72

153

1091

Bacterial infection, other or unspecified

195

2296

0.76

3.45

1.2

1.3

8.03

7.40

mmol/l

1.68

146

1612

Abnormalities of forces of labour

649

1.49

3.44

1.5

1.3

6.69

6.94

mmol/l

0.49

470

L04AD Calcineurin inhibitors

475

0.46

3.43

1.2

1.3

6.73

7.26

mmol/l

0.40

347

Other and unspecified tonsillitis

346

2393

1.23

3.41

1.4

6.81

6.70

mmol/l

0.26

249

1667

Allergic contact dermatitis

118

832

1.43

3.40

1.4

6.52

7.06

mmol/l

1.09

618

Enthesopathies of lower limb, excluding foot

163

1212

1.35

3.40

1.3

7.15

7.25

mmol/l

0.15

126

888

Cervical disc disorders

231

1803

1.28

3.39

1.2

7.57

7.46

mmol/l

0.18

177

1312

285

3254

0.80

3.38

1.3

7.66

7.18

mmol/l

1.40

207

2350

Other joint disorders

853

3978

1.14

3.37

1.3

1.4

6.95

6.89

mmol/l

0.24

638

2825

Reimbursement for rheumatic diseases

283

3509

0.80

3.36

1.3

7.24

7.20

mmol/l

0.07

204

2547

Alzheimer disease, including avohilmo

624

0.60

3.35

1.2

7.34

8.15

mmol/l

1.08

393

Bleeding

381

3349

0.83

3.34

1.2

1.3

7.65

7.35

mmol/l

0.97

273

2417

Other neurological diseases

439

2950

1.20

3.33

1.2

1.3

7.17

7.40

mmol/l

0.72

331

2102

Mental and behavioural disorders due to psychoactive substance use

306

3555

0.81

3.32

1.3

7.47

7.13

mmol/l

0.94

225

2579

Bacterial pneumoniae

161

1899

0.75

3.32

1.3

7.18

7.34

mmol/l

0.28

106

1347

Other and unspecified anaemias

122

1638

0.72

3.31

1.2

7.18

7.59

mmol/l

0.62

1160

Gastrointestinal diseases

644

2771

1.17

3.30

1.4

6.93

6.85

mmol/l

0.30

474

1958

Substance use, excluding alcohol

1183

0.66

3.29

1.3

7.24

7.04

mmol/l

0.21

875

Other anaemias

124

1654

0.72

3.28

1.2

7.21

7.58

mmol/l

0.55

1169

Hypothyroidism, other/unspecified

766

4414

1.15

3.28

1.3

1.4

7.33

6.97

mmol/l

2.10

552

3132

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

717

0.61

3.26

1.1

1.2

8.25

7.75

mmol/l

0.38

488

Infections of genitourinary tract in pregnancy

584

1.50

3.25

1.6

1.3

6.91

6.87

mmol/l

0.04

439

Peripheral artery disease

116

1303

0.71

3.22

1.3

1.2

8.08

7.87

mmol/l

0.26

894

306

3363

0.81

3.22

1.3

7.67

7.16

mmol/l

1.60

223

2430

Vascular syndromes of brain in cerebrovascular disorders

123

2.13

3.20

1.4

1.2

6.72

7.59

mmol/l

0.79

Symptoms and signs involving the digestive system and abdomen

899

3973

1.14

3.17

1.4

1.3

7.23

7.07

mmol/l

0.69

638

2831

Covid-19 suspected case

187

1435

1.31

3.17

1.2

1.4

7.90

6.84

mmol/l

1.41

1048

Dental caries 2, only avohilmo

672

4606

1.15

3.17

1.4

6.69

7.00

mmol/l

2.11

508

3293

Alzheimer disease

546

0.58

3.16

1.3

1.2

7.27

8.18

mmol/l

1.31

338

Bacterial pneumonia (organism specified)

167

1999

0.76

3.15

1.3

7.12

7.39

mmol/l

0.53

109

1433

Alzheimer’s disease, wide definition

463

0.52

3.13

1.2

6.80

8.13

mmol/l

1.43

290

Diseases of male genital organs

307

1252

1.24

3.11

1.1

7.17

7.55

mmol/l

1.22

233

902

Care involving dialysis

288

0.35

3.11

1.1

1.3

8.38

7.45

mmol/l

—

209

Labour and delivery complicated by umbilical cord complications

298

1.70

3.10

1.4

7.23

mmol/l

0.01

211

Sciatica+with lumbago

368

2900

1.21

3.10

1.3

7.20

7.22

mmol/l

0.05

281

2093

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

416

1737

1.20

3.10

1.3

1.4

6.96

6.90

mmol/l

0.15

296

1230

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

649

1.46

3.08

1.7

1.4

6.53

6.95

mmol/l

0.83

463

Other/unspecified enthesopathies of lower limb, excluding foot

329

1.65

3.08

1.3

7.25

7.18

mmol/l

0.05

250

Hyperplasia of prostate

204

897

1.30

3.07

1.2

1.1

7.21

7.67

mmol/l

1.16

149

648

Other contact dermatitis

431

1.57

3.06

1.6

1.3

6.52

7.12

mmol/l

0.74

329

KRA_PSY_EATING, excluding more controls

918

0.64

3.05

1.5

1.6

6.26

6.40

mmol/l

0.16

636

Diseases of inner ear

325

2615

1.22

3.05

1.3

7.22

7.45

mmol/l

0.59

229

1873

Substance abuse

298

3477

0.82

3.02

1.3

7.47

7.14

mmol/l

0.90

222

2526

Alcohol use disorder, Swedish definition

266

3049

0.81

3.01

1.2

1.3

7.65

7.24

mmol/l

1.09

197

2208

Dementia

862

0.69

2.98

1.2

7.82

8.03

mmol/l

0.22

561

Other disorders of eyelid

229

1756

1.26

2.97

1.3

1.2

7.54

7.65

mmol/l

0.19

158

1249

Infective dermatitis

547

1.49

2.97

1.4

1.3

6.96

7.31

mmol/l

0.50

414

Arthropathies

883

3980

1.13

2.96

1.4

6.98

6.89

mmol/l

0.39

648

2826

Temporomandibular joint disorders

138

1025

1.35

2.96

1.4

6.55

6.91

mmol/l

0.93

751

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

0.00

2.95

0.0

1.3

—

8.05

—

Kidney transplant status

196

0.30

2.92

1.2

1.3

8.16

7.24

mmol/l

—

142

Alzheimer’s disease (Late onset)

395

0.50

2.92

1.2

6.54

8.25

mmol/l

2.37

246

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

212

1832

0.79

2.91

1.2

7.63

7.55

mmol/l

0.13

159

1298

Heart failure, not strict

325

2709

0.83

2.91

1.2

7.93

7.46

mmol/l

1.51

234

1968

Puerperal sepsis

104

740

1.41

2.91

1.4

1.3

6.99

7.28

mmol/l

0.48

554

Other condition

699

1.42

2.89

1.4

1.3

7.14

7.13

mmol/l

0.01

515

564

4082

0.86

2.88

1.3

7.29

7.02

mmol/l

1.18

413

2858

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

564

4082

0.86

2.88

1.3

7.29

7.02

mmol/l

1.18

413

2858

Female infertility

365

1876

1.21

2.88

1.6

1.5

6.71

6.64

mmol/l

0.17

251

1349

L02BA Anti-estrogens

774

0.62

2.86

1.3

1.2

7.94

7.48

mmol/l

0.41

574

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

596

0.60

2.86

1.1

1.2

8.35

7.81

mmol/l

0.38

401

Heart failure,strict

168

1571

0.77

2.84

1.2

8.62

7.66

mmol/l

3.00

124

1091

Diseases of oesophagus, stomach and duodenum

847

4569

1.13

2.82

1.3

7.17

7.13

mmol/l

0.14

615

3297

Asthma, hospital admissions , main diagnosis only

655

5142

1.14

2.81

1.4

1.3

7.12

7.01

mmol/l

0.37

468

3679

All-cause Heart Failure

173

1604

0.78

2.77

1.2

8.68

7.70

mmol/l

3.24

129

1110

Organic, including symptomatic, mental disorders

132

1271

0.75

2.77

1.2

7.99

7.84

mmol/l

0.16

856

Viral haemorrhagic fevers, not elsewhere classified/unspecified

347

1.60

2.76

1.3

8.22

7.18

mmol/l

1.45

259

Hypothyreosis and Thyroxine purchase for inclusion criteria

778

4547

1.13

2.75

1.3

1.4

7.33

6.97

mmol/l

2.17

561

3232

severe traumatic brain injury, does not include concussion

815

0.64

2.75

1.3

1.2

7.50

7.55

mmol/l

0.03

575

Other diseases of the respiratory system

667

0.60

2.75

1.2

8.49

7.64

mmol/l

0.63

479

Other respiratory disorders and diseases

667

0.60

2.75

1.2

8.49

7.64

mmol/l

0.63

479

Polycystic ovarian syndrome

542

1.47

2.73

1.9

1.6

6.91

6.68

mmol/l

0.27

383

Short Achilles tendon (acquired)

125

2.02

2.72

1.4

1.3

6.14

7.22

mmol/l

1.72

Faecal incontinence

325

1.61

2.71

1.3

1.2

7.52

7.61

mmol/l

0.07

239

Pain in thoracic spine

113

826

1.37

2.71

1.4

1.3

7.06

7.17

mmol/l

0.14

606

Other osteochondropathies

341

1.59

2.71

1.3

7.03

7.18

mmol/l

0.13

252

Other/unspecified dorsalgia

269

2190

1.23

2.70

1.4

1.3

6.97

7.13

mmol/l

0.38

192

1564

Coeliac disease

625

1.43

2.70

1.6

1.4

7.06

7.20

mmol/l

0.17

467

Rheumatoid arthritis, including avohilmo

155

2007

0.77

2.69

1.3

7.48

7.42

mmol/l

0.08

104

1457

Dementia, including avohilmo

924

0.72

2.69

1.3

1.2

7.65

8.04

mmol/l

0.46

613

Tonsillectomy and adenotomy

572

3466

1.15

2.69

1.5

1.4

6.50

6.81

mmol/l

1.96

418

2493

Dental caries 2

674

4663

1.14

2.69

1.4

6.71

7.00

mmol/l

1.89

512

3328

Intrahepatic Cholestasis of Pregnancy (ICP)

586

1.45

2.67

1.8

1.5

6.29

6.86

mmol/l

1.66

421

Other cataract

153

1538

0.77

2.66

1.2

7.91

7.63

mmol/l

0.43

106

1109

Type 2 diabetes, wide definition

362

2799

0.84

2.65

1.3

1.2

10.20

6.65

mmol/l

34.77

272

2041

Autoimmune diseases related-to ILD

523

5290

0.87

2.65

1.3

7.20

7.06

mmol/l

0.43

380

3791

Bacterial pneumonia, not elsewhere classified

154

1763

0.77

2.64

1.3

7.08

7.34

mmol/l

0.50

101

1248

Malignant neoplasm of digestive organs

1341

0.73

2.63

1.1

1.2

7.48

7.79

mmol/l

0.50

933

Anorexia (incl.atypical)

493

0.54

2.63

1.3

1.6

6.21

6.67

mmol/l

0.47

346

Fentanyl

306

0.42

2.61

1.8

1.2

7.41

7.42

mmol/l

—

216

Cardiac arrhythmias

523

2993

1.16

2.61

1.2

1.3

7.08

6.44

mmol/l

5.77

408

2147

Varicose veins

386

2469

1.18

2.61

1.3

1.2

7.37

7.47

mmol/l

0.23

279

1795

Noise effects on inner ear

134

1.96

2.61

1.2

6.46

7.51

mmol/l

1.00

108

Malignant neoplasm of respiratory system and intrathoracic organs

571

0.59

2.60

1.2

8.66

7.84

mmol/l

0.48

401

Heart failure, strict

178

1626

0.79

2.58

1.2

8.63

7.70

mmol/l

3.11

131

1125

COPD, hospital admissions 1, only main diagnosis

1058

0.71

2.57

1.3

1.2

7.88

7.84

mmol/l

0.03

737

COPD, early/later onset

137

1513

0.76

2.56

1.3

1.2

7.67

7.75

mmol/l

0.09

101

1064

MS-disease / Multiple Sclerosis

463

0.54

2.56

1.6

1.4

5.88

7.12

mmol/l

2.39

335

Inflammatory disease of uterus

144

1104

1.31

2.55

1.7

1.5

7.35

6.86

mmol/l

0.99

108

797

Osteoporosis

855

0.67

2.55

1.3

1.2

7.24

7.76

mmol/l

0.66

600

Convergence insufficiency and excess

2.20

2.54

1.8

1.5

5.66

7.34

mmol/l

3.11

Chronic lower respiratory diseases

1030

5031

1.11

2.54

1.4

1.3

7.19

7.00

mmol/l

1.12

749

3591

Disorders of vestibular function (Vertigo)

268

2193

1.22

2.54

1.3

7.30

7.49

mmol/l

0.41

192

1581

Nonalcoholic fatty liver disease

411

1.52

2.54

1.4

1.3

8.12

7.37

mmol/l

0.90

307

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

143

1.92

2.53

1.7

1.5

5.93

6.88

mmol/l

—

100

Coronary angioplasty

180

1086

1.28

2.52

1.3

1.2

8.03

7.72

mmol/l

0.55

127

757

Mental and behavioural disorders due to alcohol

257

3034

0.82

2.52

1.3

7.54

7.20

mmol/l

0.82

186

2193

COPD related to multimorbidity

103

1177

0.74

2.50

1.3

1.2

7.97

7.90

mmol/l

0.06

814

Malignant neoplasm of bronchus and lung

479

0.56

2.49

1.2

8.87

7.68

mmol/l

0.69

337

Fever of other and unknown origin

282

3141

0.83

2.49

1.3

7.18

7.08

mmol/l

0.21

214

2221

Eating disorder

874

0.67

2.46

1.5

1.6

6.26

6.59

mmol/l

0.46

608

STROKE

384

2266

1.18

2.45

1.2

7.24

7.27

mmol/l

0.08

287

1643

Lung cancer and mesothelioma

596

0.63

2.45

1.1

1.2

8.29

7.75

mmol/l

0.39

406

Leiomyoma of uterus

339

2285

0.84

2.45

1.3

7.40

7.23

mmol/l

0.48

242

1691

Acute renal failure

707

0.63

2.44

1.2

8.87

7.71

mmol/l

1.32

502

Inflammatory disorders of breast

481

1.47

2.43

1.7

1.5

6.32

6.74

mmol/l

0.95

329

Malignant neoplasm of tongue

0.00

2.43

0.0

1.2

—

7.91

—

Disorders of gallbladder, biliary tract and pancreas

718

4113

1.13

2.43

1.3

7.68

7.13

mmol/l

3.96

503

3002

Other sexually transmitted chlamydial diseases

581

0.60

2.43

1.2

1.6

6.50

6.53

mmol/l

0.03

412

Hypothyroidism, drug reimbursement

143

784

1.31

2.42

1.3

1.4

7.47

6.37

mmol/l

4.01

104

545

Lateral epicondylitis

690

1.38

2.41

1.2

7.22

7.46

mmol/l

0.27

511

COPD, hospital admissions

137

1502

0.77

2.41

1.3

1.2

7.67

7.74

mmol/l

0.09

101

1053

Medical abortion

580

2763

1.14

2.40

1.4

6.80

6.84

mmol/l

0.14

426

1958

Ill-defined and unknown causes of mortality

175

0.34

2.40

1.3

1.2

5.85

7.75

mmol/l

—

122

Other disorders of binocular vision

2.25

2.40

2.0

1.5

6.35

7.45

mmol/l

1.26

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

142

1605

0.78

2.38

1.2

7.83

7.60

mmol/l

0.37

102

1134

Leiomyoma of uterus

285

1926

0.83

2.38

1.2

1.3

7.33

7.18

mmol/l

0.36

207

1409

Arthropod-borne viral fevers and viral haemorrhagic fevers

434

1.48

2.37

1.3

7.80

7.26

mmol/l

0.62

320

Testicular dysfunction

132

1.91

2.37

1.2

1.1

7.97

7.03

mmol/l

0.32

104

Diseases of the skin and subcutaneous tissue

923

4172

1.11

2.36

1.4

1.3

7.21

7.02

mmol/l

0.99

685

2987

Cerebrovascular diseases

304

2590

0.84

2.36

1.2

7.43

7.56

mmol/l

0.26

220

1867

Female infertility, associated with anovulation

120

909

1.33

2.36

1.7

1.6

6.74

6.34

mmol/l

1.04

650

Aplastic and other anaemias

150

1814

0.78

2.36

1.3

1.2

7.02

7.57

mmol/l

1.25

101

1280

Female infertility, cervigal, vaginal, other or unspecified origin

324

1827

1.19

2.35

1.5

6.57

6.65

mmol/l

0.23

234

1316

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1015

0.71

2.35

1.2

1.3

7.04

7.55

mmol/l

0.76

729

Second line medication for Crohn's disease

299

3547

0.84

2.34

1.4

1.3

7.22

7.16

mmol/l

0.10

216

2597

Implicit bacterial Sepsis

121

1452

0.76

2.32

1.2

8.24

7.63

mmol/l

0.92

1002

Inflammatory bowel disease treatment related agents

818

5164

0.90

2.30

1.3

7.22

7.01

mmol/l

1.14

606

3670

Glomerular diseases

804

0.67

2.30

1.3

7.42

7.49

mmol/l

0.06

595

Obstructed labour due to maternal pelvic abnormality

105

782

1.35

2.30

1.5

1.3

7.35

7.28

mmol/l

0.09

587

Malignant neoplasm of breast, HER-negative

862

0.68

2.29

1.2

7.27

7.55

mmol/l

0.28

625

5-aminosalicylic acid

105

1395

0.75

2.28

1.4

1.3

6.74

7.06

mmol/l

0.61

1019

Other ill-defined and unspecified causes of mortality

155

0.32

2.27

1.2

5.16

7.53

mmol/l

—

107

Non-allergic asthma (mode)

137

1051

1.30

2.27

1.4

1.3

7.67

7.11

mmol/l

1.08

100

725

ILD medications

833

5073

0.90

2.27

1.3

1.4

7.21

6.99

mmol/l

1.18

615

3605

Allergic asthma (mode), excluding more controls

223

1795

1.22

2.26

1.5

1.4

6.57

6.75

mmol/l

0.42

160

1232

L04AX Other immunosuppressants

290

3436

0.84

2.25

1.4

1.3

7.23

7.18

mmol/l

0.09

211

2513

Allergic asthma (mode)

223

1797

1.22

2.24

1.5

1.4

6.57

6.75

mmol/l

0.43

160

1233

Acute alcohol intoxication, ICD10

1139

0.73

2.24

1.3

7.36

7.13

mmol/l

0.21

837

Use of other anti-dementia drugs

486

0.61

2.24

1.2

7.90

8.08

mmol/l

0.10

302

Use of memantine

486

0.61

2.24

1.2

7.90

8.08

mmol/l

0.10

302

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

523

1.42

2.24

1.7

1.4

7.67

7.31

mmol/l

0.41

395

Other and unspecified haemorrhagic conditions

0.00

2.23

0.0

1.4

—

7.70

—

Non-allergic asthma (mode), excluding more controls

137

1054

1.29

2.23

1.4

1.3

7.67

7.13

mmol/l

1.03

100

728

Other enthesopathy of foot (+metatarsalgia)

498

1.43

2.23

1.4

1.3

7.44

7.38

mmol/l

0.06

356

Unspecific neurodegenerative disorder

756

0.72

2.21

1.2

7.64

8.06

mmol/l

0.47

481

Hernia of abdominal wall

279

2343

1.19

2.21

1.3

7.56

7.39

mmol/l

0.38

204

1676

Other or unspecified ileus, impaction or obstruction

677

0.65

2.21

1.2

7.31

7.69

mmol/l

0.35

492

Umbilical hernia

178

1430

1.25

2.20

1.3

7.42

7.39

mmol/l

0.04

133

1022

Dermatitis and eczema

879

5217

1.11

2.19

1.4

1.3

6.87

7.08

mmol/l

1.22

616

3747

Other abnormal immunological findings in serum

2.10

2.18

1.4

6.65

7.44

mmol/l

—

Parodontitis or/and operation codes

426

2916

0.87

2.18

1.3

1.4

7.29

7.00

mmol/l

1.01

299

2053

Oxycodone

117

1472

0.77

2.18

1.3

1.2

7.60

7.62

mmol/l

0.03

1020

Inflammatory bowel disease

161

2013

0.80

2.18

1.4

1.3

7.04

7.13

mmol/l

0.16

118

1470

Non-allergic asthma

385

1.49

2.18

1.7

1.3

7.89

7.16

mmol/l

0.70

278

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

650

0.64

2.17

1.3

1.2

7.63

7.77

mmol/l

0.10

448

Condition for Implicit Sepsis (Organ dysfunction codes)

479

3967

0.88

2.17

1.3

7.30

7.18

mmol/l

0.37

359

2841

Budesonide

793

0.68

2.17

1.4

7.27

7.14

mmol/l

0.11

587

Event of undetermined intent

308

0.48

2.16

1.3

1.4

7.98

7.05

mmol/l

—

219

Noninfective enteritis and colitis

241

2886

0.83

2.15

1.4

1.3

7.16

7.10

mmol/l

0.12

175

2087

Other medical care

150

1844

0.79

2.15

1.3

7.84

7.45

mmol/l

0.80

120

1277

Conjunctivitis

495

4896

0.88

2.14

1.4

6.74

7.00

mmol/l

1.23

363

3524

LSIL lesion of the vulva

130

1.87

2.13

1.3

1.4

6.78

7.18

mmol/l

0.30

Later onset COPD

567

0.66

2.13

1.2

7.59

8.15

mmol/l

0.67

369

Infections with a predominantly sexual mode of transmission

211

2555

0.82

2.13

1.4

1.5

7.30

6.69

mmol/l

1.81

149

1843

Anterior Iridocyclitis

1080

0.73

2.10

1.3

7.33

7.28

mmol/l

0.05

800

Excessive vomiting in pregnancy

496

1.42

2.10

1.5

1.3

6.61

6.83

mmol/l

0.39

369

Iridocyclitis

1229

0.75

2.10

1.2

1.3

7.36

7.26

mmol/l

0.12

902

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

174

1483

0.81

2.10

1.1

1.2

7.86

7.63

mmol/l

0.37

125

1042

Acute and subacute iridocyclitis

1021

0.72

2.09

1.3

7.40

7.26

mmol/l

0.15

762

Abnormalities of heart beat

232

1910

1.21

2.09

1.3

1.4

7.21

7.14

mmol/l

0.10

165

1362

Meniscus derangement

385

2275

1.16

2.09

1.2

7.26

7.32

mmol/l

0.11

285

1660

Mood [affective] disorders

855

5101

1.10

2.07

1.3

7.28

7.00

mmol/l

1.68

629

3639

Methotrexate

785

0.69

2.07

1.6

1.3

7.19

7.26

mmol/l

0.06

587

Testicular hypofunction

117

1.90

2.07

1.2

1.1

7.00

mmol/l

0.00

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

130

1345

0.78

2.06

1.2

7.51

7.43

mmol/l

0.11

109

978

COPD

139

1450

0.79

2.06

1.3

1.2

7.70

7.61

mmol/l

0.11

103

1019

Other obstetric trauma

366

1.49

2.06

1.8

1.4

6.44

6.87

mmol/l

0.79

260

Neuralgia and neuritis, unspecified

207

1.65

2.04

1.4

1.3

6.95

7.58

mmol/l

0.45

147

Inflammatory diseases of prostate (prostatitis)

457

1.43

2.04

1.2

7.27

7.62

mmol/l

0.42

334

Injuries to the head

745

5372

0.90

2.04

1.3

7.11

7.03

mmol/l

0.31

516

3859

Acute pharyngitis

128

993

1.28

2.03

1.5

1.4

7.36

6.83

mmol/l

1.35

105

692

Eating disorders

942

0.72

2.01

1.4

1.6

6.36

6.62

mmol/l

0.36

660

Gonarthrosis, primary, with knee surgery

270

1862

1.19

2.00

1.2

7.42

7.72

mmol/l

0.88

192

1326

Mood disorders

855

5106

1.10

1.99

1.3

7.28

7.00

mmol/l

1.76

630

3643

Seropositive rheumatoid arthritis, wide

101

1318

0.76

1.97

1.3

7.38

7.49

mmol/l

0.11

961

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

596

1.36

1.97

1.2

1.3

6.84

7.40

mmol/l

0.95

453

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.22

1.96

1.3

1.2

8.60

7.41

mmol/l

—

Acute alcohol intoxication

105

1360

0.77

1.94

1.3

7.60

7.22

mmol/l

0.46

995

Cervicobrachial syndrome

156

1256

1.25

1.94

1.3

7.37

7.23

mmol/l

0.24

118

914

Other/unspecified seropositive rheumatoid arthritis

100

1303

0.77

1.94

1.3

7.41

7.49

mmol/l

0.09

948

Myocarditis

195

1.65

1.93

1.4

1.3

6.94

7.22

mmol/l

0.23

145

Respiratory insufficiency

227

0.44

1.92

1.0

1.3

10.70

7.46

mmol/l

—

159

Abnormal findings on examination of urine, without diagnosis

165

1.71

1.91

1.4

8.29

7.37

mmol/l

0.75

119

Caught, crushed, jammed or pinched in or between objects

235

1.59

1.91

1.2

1.4

6.84

7.01

mmol/l

0.11

164

Acute posthaemorrhagic anaemia

1.93

1.90

1.4

1.3

5.84

7.36

mmol/l

4.67

Carcinoma in situ of breast, intraductal

371

0.56

1.90

1.4

1.2

6.84

7.45

mmol/l

0.49

268

Disturbances of skin sensation

220

1839

1.20

1.90

1.4

6.70

7.04

mmol/l

0.80

158

1336

Disorders of conjunctiva

542

5079

0.89

1.90

1.4

6.78

7.01

mmol/l

1.10

391

3641

Fracture of rib(s), sternum and thoracic spine

101

1310

0.77

1.90

1.2

7.66

7.51

mmol/l

0.13

946

Malignant neoplasm of other and unspecified parts of tongue

0.00

1.89

0.0

1.3

—

8.11

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1287

0.77

1.89

1.3

7.41

7.48

mmol/l

0.07

937

Other disorders of Eustachian tube

121

1.84

1.89

1.4

1.3

8.27

7.15

mmol/l

0.65

Demyelinating diseases of the central nervous system

543

0.64

1.89

1.5

1.4

5.85

7.10

mmol/l

2.80

395

Anogenital herpesviral [herpes simplex] infection

481

0.62

1.88

1.4

1.5

7.65

6.92

mmol/l

0.62

334

Mental and behavioural disorders due to alcohol, excluding acute intoxication

217

2585

0.84

1.88

1.2

1.3

7.47

7.28

mmol/l

0.34

160

1871

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

171

1442

0.82

1.86

1.1

1.2

7.93

7.63

mmol/l

0.51

122

1011

Metatarsalgia

458

1.40

1.85

1.4

1.3

7.53

7.39

mmol/l

0.14

325

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

251

0.48

1.85

1.0

1.2

7.41

7.91

mmol/l

—

167

Rheumatoid arthritis

138

1562

0.80

1.84

1.3

7.40

7.37

mmol/l

0.04

1124

Other disorders of skin and subcutaneous tissue

331

3492

0.87

1.84

1.2

1.3

7.09

7.31

mmol/l

0.60

237

2504

Lichen simplex chronicus

137

1.77

1.84

1.3

6.88

7.37

mmol/l

0.25

103

Other headache syndromes

317

2743

1.16

1.81

1.3

1.4

7.12

7.04

mmol/l

0.16

244

1966

Polypectomy (DHB20)

254

1.54

1.81

1.2

1.3

8.58

7.22

mmol/l

0.91

190

IBD patients in KELA-register

119

1501

0.79

1.80

1.4

6.96

7.02

mmol/l

0.08

1104

Alcohol use disorder, ICD-based

200

2392

0.83

1.80

1.2

1.3

7.44

7.25

mmol/l

0.32

148

1742

Amenorrhoea

667

0.69

1.80

1.4

1.6

7.24

6.42

mmol/l

1.02

487

Ovarian dysfunction

694

1.32

1.79

1.8

1.6

7.06

6.70

mmol/l

0.53

491

Intestinal stricture

1264

0.77

1.78

1.3

1.2

7.07

7.67

mmol/l

1.45

913

Fall on same level involving ice and snow

385

3382

1.14

1.78

1.3

7.22

7.18

mmol/l

0.09

267

2448

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

182

1508

0.83

1.78

1.2

7.87

7.60

mmol/l

0.50

131

1059

Achilles tendinitis

471

1.39

1.77

1.2

7.37

7.38

mmol/l

0.01

366

Other functional intestinal disorders

270

2202

1.17

1.76

1.4

1.3

7.15

7.32

mmol/l

0.37

206

1560

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

106

1350

0.78

1.76

1.4

1.5

6.33

6.73

mmol/l

1.21

967

Other, unspecified and serous retinal detachments

1.91

1.76

1.3

1.2

7.45

7.51

mmol/l

0.02

Depression

800

5030

1.10

1.76

1.3

1.4

7.21

6.98

mmol/l

1.24

591

3603

Dialysis

135

0.37

1.75

1.2

1.3

7.84

7.46

mmol/l

—

Polyarthropathies

402

3039

0.88

1.75

1.3

7.59

7.10

mmol/l

2.19

294

2192

Other (seronegative) rheumatoid arthritis, wide

885

0.73

1.75

1.3

7.58

7.48

mmol/l

0.08

654

Complications of the puerperium, not elsewhere classified

314

1.48

1.74

1.5

6.99

6.91

mmol/l

0.06

229

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1011

0.75

1.74

1.2

7.50

7.66

mmol/l

0.19

694

Explicit bacterial Sepsis

423

0.61

1.74

1.3

6.73

7.31

mmol/l

0.69

303

Other heart diseases

382

2212

1.14

1.74

1.2

1.3

7.29

6.89

mmol/l

1.62

293

1591

Use of donepezil

419

0.62

1.74

1.1

1.2

7.33

8.12

mmol/l

0.48

269

Other diseases of jaws

347

1.45

1.73

1.5

1.3

7.23

7.30

mmol/l

0.05

254

Generalized anxiety disorder

1245

0.78

1.72

1.3

1.5

6.97

6.59

mmol/l

0.51

897

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

331

1.46

1.72

1.3

7.34

7.24

mmol/l

0.08

235

Mesial bite

0.00

1.72

0.0

1.6

—

6.85

—

Carcinoma in situ of colon

0.00

1.71

0.0

1.2

—

7.67

—

Alzheimer’s disease (Late onset), excluding more controls

258

0.59

1.71

1.2

1.1

6.54

8.35

mmol/l

2.49

153

Implicit Sepsis

365

3229

0.88

1.71

1.3

7.43

7.30

mmol/l

0.30

276

2294

Special screening examination for neoplasms

133

1.74

1.70

1.2

1.3

9.29

7.60

mmol/l

0.66

All dysplastic lesions of the vulva

187

1.62

1.69

1.3

1.4

7.01

7.39

mmol/l

0.29

139

Nausea and vomiting

113

1397

0.79

1.68

1.5

1.4

6.97

7.15

mmol/l

0.23

1008

Hypothyroidism, strict autoimmune

650

3900

1.10

1.68

1.3

1.4

7.34

6.94

mmol/l

2.12

470

2774

Alzheimer’s disease, wide definition, excluding more controls

312

0.63

1.68

1.2

6.81

8.25

mmol/l

1.59

196

Other symptoms and signs involving the nervous and musculoskeletal systems

288

2491

1.16

1.68

1.4

1.3

7.18

7.17

mmol/l

0.01

201

1813

Asthma (diagnoses ohter than nonallergic)

657

5104

1.10

1.67

1.3

1.4

7.10

7.03

mmol/l

0.21

478

3639

Infections of breast associated with childbirth

309

1.47

1.67

1.7

1.6

6.13

6.75

mmol/l

1.35

218

Suggestive for eosinophilic asthma

375

1.42

1.67

1.2

1.3

7.68

7.15

mmol/l

0.49

276

Benign neoplasm of breast

668

0.70

1.66

1.3

6.34

7.36

mmol/l

1.64

479

Non-rheumatic valve diseases

190

1655

0.84

1.66

1.1

1.2

7.55

7.49

mmol/l

0.09

138

1176

Valvular heart disease excluding rheumatic fever

192

1672

0.84

1.65

1.1

1.2

7.51

7.48

mmol/l

0.05

140

1189

Diverticular disease of intestine

419

2464

1.13

1.65

1.2

7.27

7.57

mmol/l

1.14

296

1799

Coronary atherosclerosis

367

2077

1.14

1.65

1.2

7.68

7.52

mmol/l

0.44

272

1507

Heart failure and coronary heart disease

723

0.75

1.64

1.2

8.94

7.87

mmol/l

1.83

479

Diseases of the ear and mastoid process

1022

4781

1.08

1.64

1.3

1.4

7.20

6.97

mmol/l

1.28

735

3436

Blepharochalasis

138

1121

1.23

1.63

1.3

1.2

7.56

7.72

mmol/l

0.21

811

Inflammatory bowel disease, strict (require KELA)

119

1480

0.80

1.63

1.4

1.3

6.96

7.02

mmol/l

0.08

1089

Chronic kidney disease

960

0.76

1.62

1.2

8.47

7.76

mmol/l

0.95

671

Other eating disorders

462

0.64

1.62

1.7

1.6

5.94

6.57

mmol/l

1.14

321

Pedal cyclist injured in transport accident

105

1323

0.79

1.61

1.3

6.93

7.08

mmol/l

0.18

971

Recurrent or chronic depression

387

2470

1.13

1.61

1.3

1.4

6.89

6.93

mmol/l

0.10

288

1783

Seronegative rheumatoid arthritis

546

0.68

1.61

1.3

1.2

7.93

7.69

mmol/l

0.14

401

Other secondary gonarthrosis

182

1.60

1.3

1.2

7.54

mmol/l

0.00

135

Thoracic aortic aneurysm

474

0.65

1.60

1.2

7.17

7.83

mmol/l

0.84

342

Benign paroxysmal vertigo

155

1278

1.22

1.60

1.3

7.26

7.47

mmol/l

0.35

114

924

Depression or dysthymia

589

2978

1.11

1.60

1.3

7.14

7.06

mmol/l

0.23

412

2112

Primary_lymphoid and hematopoietic malignant neoplasms

950

0.76

1.60

1.2

7.34

7.56

mmol/l

0.23

663

Sulfasalazine

147

1784

0.82

1.59

1.4

1.3

7.09

7.26

mmol/l

0.25

108

1302

Other chronic obstructive pulmonary disease

136

1385

0.81

1.59

1.3

1.2

7.67

7.66

mmol/l

0.01

100

973

Mycoses

112

1398

0.80

1.59

1.2

1.3

6.98

7.29

mmol/l

0.49

1017

Nosocomial condition (hospital)

3.06

1.59

1.5

1.3

8.99

6.75

mmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

674

0.71

1.59

1.1

1.2

8.41

7.64

mmol/l

0.59

465

Invasive ventilation

249

0.52

1.59

1.5

1.3

7.55

7.36

mmol/l

—

176

Coxarthrosis, primary, with hip surgery

206

1654

1.18

1.58

1.2

7.80

7.72

mmol/l

0.11

135

1176

Ulcerative colitis

123

1517

0.81

1.57

1.3

7.15

7.08

mmol/l

0.10

1117

Malignant neoplasm of colon

471

0.66

1.56

1.2

7.43

7.80

mmol/l

0.32

335

Special screening examination for infectious and parasitic diseases

191

1691

0.84

1.56

1.4

6.66

6.68

mmol/l

0.03

148

1228

Candidiasis

694

0.72

1.56

1.2

1.4

6.78

7.28

mmol/l

0.84

509

Ocular pain

406

1.39

1.55

1.2

1.4

7.12

7.02

mmol/l

0.08

292

Spondyloarthritis

1025

0.77

1.55

1.3

6.91

7.12

mmol/l

0.26

756

Injuries to the thorax

197

2321

0.85

1.55

1.2

1.3

7.53

7.35

mmol/l

0.27

145

1663

Other disorders of veins

175

2081

0.84

1.54

1.2

1.3

7.21

7.37

mmol/l

0.27

120

1524

Nasal polyp

111

887

1.25

1.54

1.2

7.62

7.42

mmol/l

0.23

653

Other disorders starting during childhood or adolecense, excluding more controls

335

0.60

1.54

1.7

1.6

5.74

6.34

mmol/l

1.20

232

Suppurative otitis media, unspecified

153

1.65

1.54

1.4

1.5

7.36

6.82

mmol/l

0.28

101

Use of hypnotics and sedatives

711

4490

0.91

1.54

1.2

1.3

7.33

7.15

mmol/l

0.62

509

3259

Malignant neoplasm of skin

214

1888

0.85

1.53

1.1

1.2

7.71

7.67

mmol/l

0.06

155

1333

Ganglion

156

1294

1.21

1.53

1.3

6.99

7.18

mmol/l

0.37

126

931

Impacted maxillary molar

485

1.35

1.53

1.5

1.7

6.03

6.47

mmol/l

1.04

326

Unspecified fall

230

2652

0.86

1.52

1.3

7.16

7.25

mmol/l

0.17

171

1884

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

265

2300

1.15

1.52

1.5

1.4

7.25

6.76

mmol/l

1.87

204

1663

Asthma/COPD (KELA code 203)

774

5017

1.09

1.51

1.3

7.10

7.00

mmol/l

0.42

556

3583

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

918

0.76

1.50

1.2

8.16

7.66

mmol/l

0.72

632

Other deformities of toe(s)

125

0.40

1.50

1.0

1.4

9.36

7.32

mmol/l

—

TMD related operations

128

1044

1.23

1.50

1.3

1.4

6.56

7.08

mmol/l

1.79

773

Alcohol abuse, main dg, excluding more controls

905

0.76

1.49

1.3

7.41

7.03

mmol/l

0.33

678

Venous complications and haemorrhoids in pregnancy

1.83

1.48

1.9

1.3

6.24

7.22

mmol/l

—

Other anxiety disorders

343

3433

0.88

1.48

1.4

6.86

6.76

mmol/l

0.24

251

2472

Social phobias

629

0.71

1.48

1.4

1.5

7.36

6.64

mmol/l

0.77

446

Hypermobility syndrome

385

1.39

1.48

1.3

1.4

6.85

6.90

mmol/l

0.04

277

Migraine with aura and triptan purchases

152

1264

1.21

1.47

1.4

1.5

6.83

6.73

mmol/l

0.14

111

908

Dentofacial anomalies [including malocclusion]

225

1913

1.17

1.47

1.4

6.55

6.93

mmol/l

1.51

158

1396

Amputation

280

0.57

1.46

1.2

8.23

7.74

mmol/l

0.20

198

Contact with lifting and transmission devices, not elsewhere classified

1.90

1.45

1.5

1.3

7.13

7.11

mmol/l

—

Emotionally unstable personality disorder

1036

0.78

1.45

1.4

1.5

7.10

6.73

mmol/l

0.56

741

Extrapyramidal and movement disorders

136

1645

0.83

1.45

1.3

1.2

7.31

7.58

mmol/l

0.49

1185

Unspecified kidney failure

279

0.57

1.44

1.2

8.48

7.77

mmol/l

—

191

Nontoxic multinodular goitre

102

815

1.25

1.44

1.3

1.2

7.01

7.50

mmol/l

1.12

586

Follow-up examination after treatment for conditions other than malignant neoplasms

373

2171

1.13

1.44

1.4

6.90

6.96

mmol/l

0.14

261

1551

Familial hypercholesterolemia, with ischemic heart disease

261

1.46

1.43

1.2

7.07

7.49

mmol/l

0.44

186

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

630

1.29

1.43

1.2

1.3

6.84

7.57

mmol/l

1.37

466

Preparation and fitting of bite rail to mouth

103

826

1.25

1.42

1.3

1.4

6.56

7.09

mmol/l

1.50

611

Colorectal cancer

785

0.75

1.42

1.1

1.2

7.58

7.86

mmol/l

0.29

550

Vitreous haemorrhage

375

0.64

1.40

1.1

1.2

9.44

7.37

mmol/l

1.34

274

Ankylosing spondylitis, ICD10

423

0.66

1.40

1.4

1.3

7.31

7.14

mmol/l

0.11

313

Non-ischemic cardiomyopathy

839

0.78

1.40

1.1

1.2

8.43

7.68

mmol/l

1.02

583

Other disorders of binocular movement

134

1.66

1.40

1.7

1.4

6.17

7.24

mmol/l

1.23

Other and unspecified iron deficiency

136

1637

0.83

1.40

1.4

1.3

6.94

7.32

mmol/l

0.76

1171

Car occupant injured in other and unspecified transport accidents

146

1217

1.20

1.39

1.6

1.4

6.97

6.92

mmol/l

0.09

112

879

Other mental disorders due to brain damage and dysfunction and to physical disease

362

0.63

1.39

1.5

1.2

8.43

7.73

mmol/l

0.40

252

Effects of other external causes

142

1.63

1.39

1.5

1.4

6.73

7.20

mmol/l

0.55

Carcinoma in situ of breast, intraductal

337

0.62

1.38

1.4

1.2

6.84

7.67

mmol/l

0.73

247

Vulvovaginal ulceration/inflammation in other diseases

444

0.67

1.37

1.4

1.5

6.98

6.87

mmol/l

0.08

305

Lichen planus

494

1.32

1.37

1.2

7.66

7.42

mmol/l

0.22

369

Viral pneumonia (unknown virus, not influenza)

311

0.61

1.36

1.4

1.3

6.30

7.13

mmol/l

1.19

225

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1193

0.80

1.36

1.2

10.15

6.80

mmol/l

7.35

892

Pollen allergy

113

1365

0.82

1.36

1.4

1.5

6.27

6.69

mmol/l

1.06

974

Diseases of external ear

153

1816

0.84

1.35

1.3

7.55

7.26

mmol/l

0.42

116

1313

Other congenital malformations of face and neck

151

1.60

1.35

1.3

1.4

8.08

7.14

mmol/l

0.59

100

Other and unspecified disorders of pigmentation

0.00

1.35

0.0

1.3

—

7.22

—

Exfoliative dermatitis

0.00

1.35

0.0

1.2

—

7.83

—

Alzheimer disease, excluding more controls

337

0.69

1.35

1.3

1.2

7.03

8.29

mmol/l

1.76

210

Follicular cysts of skin and subcutaneous tissue

114

931

1.23

1.34

1.2

1.3

7.74

7.21

mmol/l

0.76

693

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

0.00

1.34

0.0

1.3

—

7.45

—

Type 1 diabetes, wide definition, subgroup 2

0.00

1.34

0.0

1.4

—

6.79

—

Other specified and unspecified disorders of conjunctiva

0.00

1.34

0.0

1.4

—

7.66

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

0.00

1.34

0.0

1.4

—

7.48

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1091

0.80

1.34

1.3

6.70

7.04

mmol/l

0.60

798

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.93

1.34

1.1

1.5

7.38

7.01

mmol/l

—

Coxarthrosis, primary

275

2097

1.14

1.33

1.2

7.93

7.66

mmol/l

0.62

179

1514

Oedema, not elsewhere classified

181

1536

1.17

1.33

1.4

1.3

7.45

7.46

mmol/l

0.02

126

1066

Carcinoma in situ of colon

0.00

1.33

0.0

1.1

—

7.40

—

Macular pucker

465

0.69

1.33

1.1

1.2

6.49

7.82

mmol/l

1.88

333

Speech and linguistic disorders, excluding more controls

504

0.71

1.33

1.4

1.6

6.80

6.48

mmol/l

0.35

352

Other congenital malformations of intestine

0.00

1.32

0.0

1.4

—

7.48

—

Medial epicondylitis

168

1.56

1.32

1.3

7.90

7.54

mmol/l

0.22

121

Adjustment and management of implanted device

569

0.72

1.31

1.1

1.2

8.67

7.84

mmol/l

0.65

388

Later onset COPD, excluding more controls

472

0.73

1.31

1.2

7.54

7.84

mmol/l

0.29

296

Other/unspecified disorders of vestibular function

121

1.66

1.31

1.4

1.3

7.27

7.59

mmol/l

0.09

Nontraumatic intracranial haemmorrhage

683

0.74

1.31

1.2

7.69

7.66

mmol/l

0.02

482

Spirochaetal infections, other/unspecified

319

0.62

1.30

1.2

1.3

6.01

7.38

mmol/l

1.21

233

Other noninfective gastroenteritis and colitis

106

1295

0.82

1.30

1.4

1.3

7.32

7.17

mmol/l

0.21

932

Other bullous disorders

106

1.71

1.30

1.4

6.15

7.34

mmol/l

1.46

Soft tissue disorders related to use, overuse and pressure

152

1282

1.19

1.29

1.2

8.23

7.50

mmol/l

1.80

109

932

Disorders of continuity of bone

447

1.32

1.29

1.4

1.3

6.70

7.33

mmol/l

1.19

330

Other/unspecified synovitis and tenosynovitis

561

1.29

1.28

1.5

1.3

7.49

7.43

mmol/l

0.06

406

Other viral diseases

175

2036

0.86

1.28

1.3

1.4

6.61

6.91

mmol/l

0.82

132

1474

Primary_lymphoid and hematopoietic malignant neoplasms

916

0.78

1.27

1.2

7.34

7.68

mmol/l

0.39

662

Migraine without aura

181

1553

1.17

1.27

1.5

6.56

6.67

mmol/l

0.22

143

1096

Meralgia paraesthetica

146

1.59

1.26

1.4

1.3

6.33

7.39

mmol/l

1.23

104

Misadventures to patients during surgical and medical care

651

1.26

1.3

7.30

7.29

mmol/l

0.01

482

Oral corticosteroids

748

4880

0.93

1.26

1.3

7.26

7.05

mmol/l

1.06

569

3486

Immunodeficiency with predominantly antibody defects

116

0.43

1.25

1.2

1.4

5.76

7.27

mmol/l

—

Diseases of pulp and periapical tissues

236

2066

1.14

1.25

1.4

1.3

7.15

7.20

mmol/l

0.08

181

1520

Other benign neoplasms of connective and other soft tissue

423

1.33

1.25

1.4

1.3

6.68

7.20

mmol/l

0.73

311

Ulcerative colitis (strict definition, all Crohn cases excluded)

835

0.78

1.24

1.3

1.4

6.67

7.03

mmol/l

0.62

610

Hypothyroidism, strict autoimmune, 3 medication purchases required

688

4337

1.08

1.24

1.3

1.4

7.30

6.96

mmol/l

1.76

503

3083

Benign lipomatous neoplasm

169

1444

1.17

1.24

1.2

6.84

7.48

mmol/l

2.20

133

1060

COPD (mode)

109

1051

0.82

1.24

1.3

1.2

7.80

7.53

mmol/l

0.33

725

Causalgia

1.78

1.24

1.3

1.4

7.06

7.42

mmol/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

139

1.59

1.23

1.3

7.45

7.87

mmol/l

0.21

Other diseases of blood and blood-forming organs, wide

1034

0.80

1.23

1.3

7.51

7.42

mmol/l

0.08

767

Crushed, pushed or stepped on by crowd or human stampede

386

0.67

1.23

1.4

6.61

6.84

mmol/l

0.21

269

Impingement syndrome of shoulder

139

1170

1.19

1.23

1.2

7.64

7.62

mmol/l

0.02

857

In situ neoplasms

163

1817

0.85

1.22

1.3

1.4

7.84

7.25

mmol/l

1.00

119

1267

Injuries to the hip and thigh

192

2029

0.86

1.22

1.3

7.45

7.43

mmol/l

0.03

152

1417

Peripheral arterial reconstruction

468

0.70

1.22

1.2

7.81

7.89

mmol/l

0.05

318

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

156

1.55

1.21

1.3

1.5

6.53

7.04

mmol/l

0.50

118

Seropositive rheumatoid arthritis

102

1237

0.82

1.20

1.3

7.43

7.58

mmol/l

0.16

904

Streptococcal septicaemia

312

0.64

1.20

1.2

1.3

7.06

7.38

mmol/l

0.27

226

Ankylosing spondylitis

407

0.69

1.19

1.4

1.3

7.31

7.18

mmol/l

0.08

308

Disorders of mineral metabolism

289

1.39

1.19

1.2

1.3

7.10

7.36

mmol/l

0.25

212

Colectomy operation

615

0.75

1.19

1.3

1.2

7.99

7.61

mmol/l

0.35

443

Alcoholic liver disease

383

0.68

1.19

1.3

1.2

9.67

7.55

mmol/l

1.67

285

Use of levodopa decarboxylase inhibitor

383

0.68

1.19

1.3

1.2

7.29

7.82

mmol/l

0.44

268

Granulomatous disorders of skin and subcutaneous tissue

117

1.64

1.18

1.2

1.4

6.83

7.13

mmol/l

0.21

Bullous disorders

181

1.50

1.18

1.4

7.79

7.47

mmol/l

0.13

126

Selective serotonin reuptake inhibitors

854

4194

1.07

1.18

1.3

1.4

7.31

7.00

mmol/l

1.64

592

3003

Other antidepressants

861

4192

1.07

1.18

1.2

1.4

7.36

7.00

mmol/l

2.22

616

3001

Symptoms and signs involving the skin and subcutaneous tissue

476

4332

1.09

1.18

1.4

1.3

6.93

7.14

mmol/l

0.80

354

3094

Temporomandibular joint disorders, including avohilmo

368

3321

1.11

1.17

1.4

1.5

6.51

6.81

mmol/l

1.48

265

2402

Mood disorders, excluding more controls

787

4460

1.07

1.17

1.3

7.34

7.01

mmol/l

1.92

576

3183

Acute laryngitis and tracheitis

763

1.23

1.17

1.4

1.5

6.38

6.75

mmol/l

0.56

528

Malignant neoplasm of bone and articular cartilage

0.00

1.17

0.0

1.1

—

8.17

—

Symptoms and signs involving speech and voice

144

1691

0.85

1.17

1.3

7.09

7.42

mmol/l

0.76

108

1218

Malignant neoplasm of parotid gland

0.00

1.16

0.0

1.1

—

7.97

—

Amblyopia ex anopsia

190

1.48

1.16

1.3

1.4

6.93

6.85

mmol/l

0.06

128

Benign neoplasm: Adrenal gland

265

1.40

1.16

1.2

1.3

7.42

7.58

mmol/l

0.11

197

Erosion of teeth, including avohilmo

127

1455

0.84

1.16

1.4

6.82

6.77

mmol/l

0.06

970

Seropositive rheumatoid arthritis, strict definition

714

0.77

1.16

1.3

7.17

7.37

mmol/l

0.17

534

Viral infections of the central nervous system

357

0.67

1.16

1.3

1.4

5.93

7.07

mmol/l

1.56

260

314

2792

1.12

1.16

1.4

7.06

7.00

mmol/l

0.13

223

2011

Left ventricular outflow tract obstruction, narrow definition

182

1.49

1.16

1.3

7.50

7.35

mmol/l

0.06

134

Right side

2.54

1.16

1.0

1.1

—

7.45

—

Coxarthrosis

271

1629

1.13

1.16

1.2

7.91

7.58

mmol/l

0.81

178

1187

Benign lipomatous neoplasm

169

1455

1.16

1.15

1.2

6.84

7.45

mmol/l

2.09

133

1037

Hypertrichosis

150

1.55

1.15

1.4

1.5

8.40

6.89

mmol/l

0.71

101

Stroke, including SAH

245

2051

0.88

1.15

1.2

7.67

7.65

mmol/l

0.03

178

1452

Trigger finger

678

1.24

1.15

1.2

7.10

7.58

mmol/l

0.75

498

Deposits [accretions] on teeth

286

0.64

1.14

1.1

1.3

7.35

7.04

mmol/l

0.15

204

Hypermetropia

317

1.36

1.14

1.6

1.4

6.59

6.95

mmol/l

0.39

224

Focal epilepsy, strict definition

935

0.80

1.14

1.3

6.89

7.23

mmol/l

0.32

680

Benign neoplasm: Colon

244

2112

1.13

1.14

1.2

7.44

7.65

mmol/l

0.47

179

1511

Aortic aneurysm

744

0.78

1.14

1.2

8.05

7.89

mmol/l

0.13

514

Urolithiasis

170

1466

1.16

1.14

1.3

1.2

7.74

7.45

mmol/l

0.61

123

1060

Dental caries 3 and operation codes, only avohilmo

256

1134

1.14

1.4

1.3

6.94

6.82

mmol/l

0.21

177

816

Heterophoria

457

1.30

1.13

1.4

7.44

6.99

mmol/l

0.52

320

Opioids

901

4430

1.07

1.13

1.4

7.24

6.94

mmol/l

1.81

698

3102

Diaphragmatic hernia

182

1579

1.15

1.13

1.3

1.2

7.40

7.61

mmol/l

0.43

139

1110

Suicide or other Intentional self-harm

143

1673

0.85

1.12

1.3

1.4

7.79

6.95

mmol/l

2.16

112

1214

Haemorrhage from respiratory passages

166

1327

1.16

1.12

1.2

1.3

7.56

7.48

mmol/l

0.12

117

935

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

455

0.72

1.12

1.1

1.2

8.23

7.84

mmol/l

0.21

318

Endocarditis

115

0.43

1.12

1.2

1.3

8.42

7.47

mmol/l

—

Benign neoplasm of breast

619

0.76

1.11

1.3

6.34

7.33

mmol/l

1.57

454

Other symptoms and signs involving the digestive system and abdomen

102

844

1.21

1.11

1.3

7.51

7.32

mmol/l

0.25

626

Focal epilepsy

1063

0.82

1.11

1.3

6.84

7.26

mmol/l

0.51

767

Ménière disease

345

1.34

1.11

1.2

1.3

7.75

7.58

mmol/l

0.13

249

Acute gastritis

285

1.37

1.10

1.3

7.17

7.46

mmol/l

0.16

209

Alcohol abuse, main dg

864

0.80

1.10

1.3

7.41

7.11

mmol/l

0.25

637

In situ neoplasms

163

1884

0.86

1.09

1.3

7.84

7.28

mmol/l

0.93

119

1338

Malignant neoplasm of breast, HER-positive

129

1496

0.85

1.08

1.2

7.51

7.47

mmol/l

0.05

109

1085

Other complications of labour and delivery, not elsewhere classified

123

1001

1.19

1.08

1.7

1.5

6.19

6.43

mmol/l

0.44

679

Specific personality disorders

160

1849

0.86

1.08

1.3

1.4

7.39

6.82

mmol/l

1.60

116

1344

Cerebrovascular diseases (FINNGEN)

202

1265

1.14

1.07

1.3

1.2

7.33

7.13

mmol/l

0.33

152

918

Heartburn

523

1.27

1.07

1.3

1.4

7.22

7.17

mmol/l

0.04

391

Internal derangement of knee

207

2343

0.88

1.07

1.3

7.10

7.17

mmol/l

0.09

155

1689

Basal cell carcinoma, including avohilmo

192

1725

0.88

1.06

1.2

7.85

7.72

mmol/l

0.20

135

1215

Anisometropia and aniseikonia

129

1.56

1.06

1.2

1.4

6.85

7.50

mmol/l

0.51

Other diseases of oesophagus

348

1.33

1.05

1.4

1.3

7.16

7.70

mmol/l

0.48

254

Paralytic ileus and intestinal obstruction

1034

0.82

1.05

1.3

1.2

7.35

7.73

mmol/l

0.60

749

Fibroblastic disorders

116

978

1.19

1.05

1.2

7.25

7.78

mmol/l

0.97

705

Other disorders of iris and ciliary body

1.68

1.04

1.1

1.3

7.89

7.54

mmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

383

0.70

1.04

1.4

7.29

6.82

mmol/l

0.28

272

Stroke, excluding SAH

224

1878

0.89

1.04

1.2

7.72

7.64

mmol/l

0.12

162

1319

Nutritional anaemias

211

2321

0.88

1.04

1.3

7.25

7.36

mmol/l

0.18

142

1648

Phobic anxiety disorders

1021

0.82

1.04

1.3

1.5

7.38

6.59

mmol/l

1.52

721

Other shoulder lesions

437

1.29

1.03

1.4

1.3

8.03

7.31

mmol/l

0.68

318

Benign neoplasm: Colon, unspecified

108

906

1.19

1.03

1.3

1.2

7.61

7.86

mmol/l

0.36

655

Congenital malformations of genital organs

685

0.78

1.03

1.5

7.04

6.88

mmol/l

0.17

482

Female genital prolapse

196

990

1.14

1.03

1.3

7.55

7.25

mmol/l

0.61

146

726

Pleural plaque

252

0.63

1.03

1.1

1.2

7.66

7.75

mmol/l

—

185

Preparatory care for dialysis

151

0.53

1.03

1.1

1.3

8.04

7.26

mmol/l

—

109

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

288

1.31

1.02

1.2

7.05

6.49

mmol/l

0.71

193

Mucosal proctocolitis

733

0.79

1.02

1.3

1.4

6.79

7.03

mmol/l

0.31

531

Family history of certain disabilities and chronic diseases leading to disablement

307

1.34

1.02

1.4

6.97

6.70

mmol/l

0.26

214

Behavioural syndromes associated with physiological disturbances and physical factors

223

2507

0.89

1.02

1.4

6.84

6.73

mmol/l

0.20

162

1799

Burn and corrosion of wrist and hand

163

1.48

1.02

1.3

1.4

7.06

7.16

mmol/l

0.06

115

Thyrotoxicosis with diffuse goitre

826

1.20

1.01

1.4

6.91

6.96

mmol/l

0.06

602

Otitis externa

106

1258

0.84

1.01

1.4

1.3

7.62

7.18

mmol/l

0.53

918

Hirsutism in women

139

1.53

1.01

1.4

1.5

8.00

6.87

mmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

908

0.81

1.01

1.3

6.47

7.22

mmol/l

1.53

661

Intracerebral haemorrhage

345

0.69

1.00

1.0

1.2

8.32

7.83

mmol/l

0.28

237

Congenital malformations of eye, ear, face and neck

369

1.31

1.00

1.4

1.5

7.36

6.86

mmol/l

0.52

254

Pacemaker

978

0.82

1.00

1.1

1.2

7.98

7.90

mmol/l

0.06

659

Alcohol dependence

116

1363

0.85

0.99

1.3

1.2

7.62

7.37

mmol/l

0.31

1012

Other disorders starting during childhood or adolescence

306

0.68

0.99

1.7

1.6

5.74

6.44

mmol/l

1.44

213

Other disorders of eye and adnexa

719

1.21

0.99

1.3

1.4

7.01

7.12

mmol/l

0.13

531

Voice disturbances

118

1384

0.85

0.99

1.3

7.13

7.35

mmol/l

0.38

1012

Injuries to the elbow and forearm

424

4165

0.92

0.98

1.3

6.90

7.09

mmol/l

0.67

305

3001

Mandibular retrognathia AND surgery (BSSRO)

148

1.50

0.98

1.2

1.4

6.58

7.31

mmol/l

0.58

107

Injury of cranial nerves

0.00

0.98

0.0

1.4

—

7.34

—

Recurring oral aphthae, including avohilmo

656

1.22

0.98

1.4

6.74

7.22

mmol/l

0.73

484

Acute pancreatitis (for exclusion)

861

0.81

0.98

1.3

1.2

7.91

7.54

mmol/l

0.36

640

Childhood asthma (age<16)

147

1008

1.16

0.98

1.7

1.5

6.12

6.27

mmol/l

0.36

104

652

Other specific joint derangements/joint disorders

630

3938

1.07

0.98

1.3

1.4

7.12

6.88

mmol/l

1.12

475

2804

Calculus of kidney and ureter

157

1366

1.15

0.97

1.3

1.2

7.77

7.43

mmol/l

0.71

116

991

Concussion

372

2942

1.10

0.97

1.4

7.20

6.93

mmol/l

1.07

262

2070

Other malignant neoplasms of skin (=non-melanoma skin cancer)

181

1625

0.88

0.97

1.1

1.2

7.85

7.73

mmol/l

0.18

129

1142

ILD medications: azathioprine

893

0.82

0.97

1.4

6.89

7.04

mmol/l

0.19

653

Radial styloid tenosynovitis [de Quervain]

301

1.33

0.97

1.3

1.4

6.57

7.28

mmol/l

1.19

214

Lung transplant status

0.00

0.97

0.0

1.2

—

8.55

—

Lung transplantation

0.00

0.97

0.0

1.2

—

8.55

—

Dependence on enabling machines and devices, not elsewhere classified

0.00

0.96

0.0

1.1

—

7.97

—

Other diseases of the digestive system

108

1273

0.85

0.96

1.2

7.85

7.56

mmol/l

0.39

904

Childhood asthma (age<16), excluding more controls

147

1009

1.16

0.96

1.7

1.5

6.12

6.29

mmol/l

0.43

104

652

Unspecified privation

480

0.75

0.96

1.4

1.3

7.24

7.11

mmol/l

0.09

354

Subacute thyroiditis

157

1.47

0.96

1.4

1.3

5.87

7.28

mmol/l

1.60

109

Atrial fibrillation and flutter

193

1109

1.14

0.96

1.2

7.61

7.15

mmol/l

1.17

156

809

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.70

0.95

1.1

1.5

7.38

7.03

mmol/l

—

Crystalline deposits in vitreous body

0.00

0.95

0.0

1.2

—

7.43

—

Convulsions, not elsewhere classified

122

1404

0.86

0.95

1.3

1.4

7.25

7.06

mmol/l

0.21

992

Sequelae of injuries of upper limb

443

1.27

0.95

1.3

7.01

7.15

mmol/l

0.12

332

Plantar fascial fibromatosis

452

1.26

0.95

1.3

1.2

6.97

7.45

mmol/l

0.58

331

Basal cell carcinoma

186

1678

0.88

0.94

1.1

1.2

7.90

7.74

mmol/l

0.26

131

1182

Other viral hepatitis

340

0.70

0.94

1.2

1.3

6.93

6.91

mmol/l

0.01

245

Medicines for HER+ breast cancer

150

1675

0.87

0.94

1.3

7.47

7.40

mmol/l

0.10

120

1213

Calculus of lower urinary tract

158

1.46

0.93

1.2

1.3

7.24

7.44

mmol/l

0.11

114

Azathioprine

888

0.82

0.93

1.4

6.89

7.09

mmol/l

0.25

655

Ulcerative colitis (strict definition, require KELA)

997

0.83

0.93

1.3

1.4

6.75

7.02

mmol/l

0.42

728

LeFortI or BSSRO operation

243

1.37

0.93

1.2

1.4

6.78

6.96

mmol/l

0.12

175

N06DA Anticholinesterases

640

0.81

0.93

1.2

8.01

8.06

mmol/l

0.04

410

Use of anticholinesterases

640

0.81

0.93

1.2

8.01

8.06

mmol/l

0.04

410

Secondary parkinsonism, excluding more controls

1.72

0.93

1.3

7.21

7.20

mmol/l

—

Medical observation and evaluation for suspected diseases and conditions

540

2567

1.08

0.92

1.3

7.13

6.97

mmol/l

0.55

395

1832

Glaucoma suspect

169

1485

1.14

0.92

1.2

7.84

7.59

mmol/l

0.46

134

1056

Disorders of thyroid, IBD co-morbidities

155

985

1.15

0.92

1.4

6.71

6.32

mmol/l

1.01

110

675

Benign lipomatous neoplasm of other sites/unspecified

304

1.32

0.92

1.1

1.3

7.44

7.46

mmol/l

0.01

225

Secondary parkinsonism+Parkinsonism in other disease

1.68

0.91

1.2

1.3

7.20

7.44

mmol/l

—

Cholecystitis

499

1.24

0.91

1.1

1.2

7.44

7.56

mmol/l

0.08

355

Osteoporosis with pathological fracture (FG)

171

0.58

0.91

1.1

1.2

8.18

7.98

mmol/l

—

114

Lung diseases due to external agents

430

0.74

0.91

1.2

7.29

7.49

mmol/l

0.10

311

Benign neoplasm: Choroid

201

1.40

0.91

1.3

6.59

7.52

mmol/l

1.62

142

Peripheral artery operations in Hilmo

361

0.72

0.91

1.1

1.2

8.23

7.79

mmol/l

0.26

255

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

295

3242

0.91

1.2

1.3

7.38

7.26

mmol/l

0.22

199

2342

Other diseases of liver

827

1.19

0.91

1.3

7.85

7.34

mmol/l

0.79

610

Abnormalities of gait and mobility

407

0.74

0.91

1.5

1.3

7.48

7.58

mmol/l

0.06

285

Colon adenocarcinoma

361

0.72

0.91

1.2

7.53

7.75

mmol/l

0.15

255

Open wound of head

251

2740

0.90

0.91

1.3

7.03

7.37

mmol/l

0.82

177

1963

Other chronic obstructive pulmonary disease, including avohilmo

200

1868

0.89

0.90

1.3

1.2

7.70

7.66

mmol/l

0.05

146

1323

Chronic ulcer of skin, not elsewhere classified

207

0.63

0.90

1.2

1.3

8.07

7.55

mmol/l

—

148

Other and unspecified vascular occlusions

279

1.33

0.90

1.3

1.2

8.56

7.80

mmol/l

0.63

197

Major coronary heart disease event

356

2174

1.09

0.89

1.2

7.89

7.54

mmol/l

1.16

259

1566

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

654

3991

1.07

0.89

1.3

7.26

mmol/l

0.00

487

2889

Pedal cyclist injured in noncollision transport accidents

574

0.78

0.89

1.3

6.94

7.06

mmol/l

0.09

426

Codeine or tramadol medication

941

4936

1.06

0.89

1.3

1.4

7.28

7.00

mmol/l

1.79

718

3477

Atypical facial pain

228

1.37

0.88

1.3

7.30

7.47

mmol/l

0.10

168

Benign neoplasm: Adrenal gland

280

1.33

0.88

1.2

1.3

7.42

7.75

mmol/l

0.24

209

Myocardial infarction, unclassifiable

552

0.79

0.88

1.1

1.2

9.01

7.82

mmol/l

1.39

374

Other maltreatment syndromes

152

1.46

0.88

1.5

1.4

7.03

7.34

mmol/l

0.15

108

Fracture at wrist and hand level

181

2037

0.89

0.88

1.3

6.96

7.15

mmol/l

0.33

137

1485

Acute and transient psychotic disorders

629

1.21

0.88

1.3

8.70

7.05

mmol/l

2.43

473

Alcohol withdrawal state with delirium

265

0.68

0.88

1.1

1.2

8.26

7.34

mmol/l

0.59

196

Other diseases of arteries and capillaries

335

0.71

0.87

1.2

1.3

7.68

7.63

mmol/l

0.02

241

Pulmonary heart disease, diseases of pulmonary circulation

111

1292

0.86

0.87

1.2

8.50

7.59

mmol/l

1.49

944

Inguinal or femoral hernia, bilateral

381

0.73

0.87

1.2

7.55

7.75

mmol/l

0.11

263

Other and unspecified injuries of wrist and hand

169

1.43

0.87

1.3

1.4

7.29

7.05

mmol/l

0.10

112

Secondary uncertain malignant neoplasm

438

0.75

0.87

1.2

1.3

7.67

7.53

mmol/l

0.08

317

Spondylopathies (FG)

870

0.83

0.87

1.4

1.3

6.80

7.14

mmol/l

0.51

640

Lichen ruber planus, wide definition including periferal and oral lichen planus

111

951

1.17

0.87

1.2

7.67

7.44

mmol/l

0.25

707

Gout due to impairment of renal function

2.02

0.87

1.0

1.2

9.57

7.71

mmol/l

—

Melanocytic naevi of trunk

672

0.80

0.87

1.3

1.4

6.62

7.17

mmol/l

0.74

493

Disorders of adult personality and behaviour

202

2258

0.89

0.87

1.3

1.4

7.21

6.81

mmol/l

1.25

150

1637

Any reimbursement code in KELA

636

2984

1.07

0.87

1.4

7.38

6.35

mmol/l

10.51

466

2124

Infections of the skin and subcutaneous tissue

400

3678

1.08

0.87

1.4

1.3

7.16

7.08

mmol/l

0.20

296

2645

Other disorders of cornea

378

1.27

0.86

1.3

7.40

7.37

mmol/l

0.01

280

Postmenopausal atrophic vaginitis

133

693

1.16

0.86

1.2

7.06

7.57

mmol/l

1.25

104

507

Generalized epilepsy, strict definition

120

1.51

0.86

1.2

1.5

7.89

7.27

mmol/l

0.35

Retention of urine

109

1073

0.86

0.85

1.2

7.52

7.70

mmol/l

0.25

732

Fracture of forearm

299

3065

0.91

0.85

1.3

6.79

7.17

mmol/l

1.51

216

2223

Dermatitis herpetiformis

1.68

0.85

1.4

1.3

5.66

7.49

mmol/l

—

Other and unspecified coagulation defects

247

1.34

0.85

1.4

6.38

7.19

mmol/l

1.17

170

Embedded and impacted teeth

266

2051

1.10

0.85

1.5

1.6

6.29

6.41

mmol/l

0.43

188

1418

Vasomotor rhinitis (mode)

317

1.30

0.85

1.2

1.3

7.51

7.48

mmol/l

0.02

229

Myeloproliferative diseases

298

0.70

0.85

1.0

1.3

7.90

7.53

mmol/l

0.18

217

Symptoms and signs involving the urinary system

454

3257

1.08

0.85

1.3

7.46

7.31

mmol/l

0.43

347

2317

Lesion of plantar nerve

230

1.35

0.85

1.3

7.04

7.77

mmol/l

0.67

172

COPD-related respiratory insufficiency

344

0.73

0.84

1.2

8.30

7.78

mmol/l

0.29

245

Algoneurodystrophy

179

1.40

0.84

1.4

1.3

7.71

7.18

mmol/l

0.26

128

Congenital malformations of great arteries

1.67

0.84

1.2

1.5

5.49

7.30

mmol/l

—

Benign neoplasm: Colon, unspecified

108

923

1.17

0.83

1.3

1.2

7.61

7.64

mmol/l

0.03

636

Injury of muscle and tendon at hip and thigh level

416

1.25

0.83

1.2

1.3

7.00

7.32

mmol/l

0.41

307

Other and unspecified psoriasis

257

1.33

0.83

1.4

1.3

8.31

7.35

mmol/l

0.73

192

Obsessive-compulsive disorder

523

0.78

0.83

1.4

1.6

7.31

6.63

mmol/l

0.61

373

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

354

0.73

0.83

1.2

7.53

7.90

mmol/l

0.27

242

Symptoms and signs involving the nervous and musculoskeletal systems

364

3356

1.09

0.83

1.3

7.19

mmol/l

0.01

263

2394

Trochanteric bursitis

570

1.21

0.82

1.2

8.45

7.69

mmol/l

1.01

412

Nontoxic goitre/thyroid nodule

155

1368

1.13

0.82

1.3

7.22

7.48

mmol/l

0.52

121

993

Autism spe

113

1.51

0.82

1.2

1.5

6.67

6.98

mmol/l

0.16

Other puerperal infections

708

1.19

0.82

1.8

1.6

6.56

6.66

mmol/l

0.08

497

Pre-eclampsia superimposed on chronic hypertension

1.90

0.82

1.0

1.7

8.47

6.77

mmol/l

—

Disorders of puberty

1.66

0.82

1.5

1.7

5.20

6.79

mmol/l

—

Inguinal hernia, bilateral

376

0.74

0.82

1.2

7.55

7.74

mmol/l

0.11

259

Other and unspecified effects of external causes

206

1851

1.11

0.82

1.4

7.23

6.89

mmol/l

0.75

150

1345

Chronic periodontitis

622

0.80

0.81

1.1

1.2

7.28

7.53

mmol/l

0.21

461

Maxillary retrognathism

1.58

0.81

1.2

1.5

6.07

6.98

mmol/l

—

Abnormal findings on diagnostic imaging of lung

177

1932

0.89

0.81

1.2

7.28

7.66

mmol/l

0.69

120

1386

Other symptoms and signs involving cognitive functions and awareness

219

1851

1.11

0.81

1.2

7.10

7.54

mmol/l

1.42

171

1324

Inflammatory diseases of the central nervous system

364

0.74

0.81

1.3

6.60

7.17

mmol/l

0.38

265

Benign neoplasm of brain and other parts of central nervous system

258

1.32

0.81

1.2

1.3

6.62

7.42

mmol/l

1.36

186

Presbycusis

274

1.31

0.81

1.2

8.83

7.89

mmol/l

0.62

180

Myocardial infarction, with ST-elevation

544

1.21

0.81

1.2

7.66

7.89

mmol/l

0.24

394

Other disorders of teeth and supporting structures

125

1089

1.15

0.81

1.2

1.3

6.90

7.45

mmol/l

1.24

789

Direct fill therapy

672

1.19

0.81

1.3

7.36

7.10

mmol/l

0.33

491

Acute suppurative otitis media

192

1998

0.90

0.80

1.5

6.95

6.59

mmol/l

0.64

152

1420

Certolizumab pegol

114

1.50

0.80

1.9

1.5

6.69

6.87

mmol/l

0.11

Juvenile arthritis (FINNGEN)

294

0.71

0.80

1.3

1.5

5.90

6.94

mmol/l

2.45

214

Dental pulpitis 3

132

830

1.15

0.80

1.7

6.32

6.16

mmol/l

0.41

561

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

151

1553

0.88

0.80

1.5

1.6

6.67

6.43

mmol/l

0.42

107

1092

Idiopathic gout

285

1.30

0.80

1.2

9.23

7.45

mmol/l

2.27

206

Viral meningitis

200

0.65

0.80

1.4

5.23

7.03

mmol/l

—

139

Exposure to ignition of highly flammable material

0.00

0.80

0.0

1.1

—

8.17

—

Mental and behavioural disorders due to hallucinogens

0.00

0.79

0.0

1.3

—

7.37

—

Endometriosis

285

1856

0.91

0.79

1.3

1.5

6.96

6.75

mmol/l

0.68

196

1329

Personality disorders, excluding more controls

194

2159

0.90

0.79

1.4

7.32

6.74

mmol/l

2.00

145

1560

Other congenital malformations of brain

0.00

0.79

0.0

1.5

—

7.37

—

Malignant neoplasm of base of tongue

0.00

0.79

0.0

1.2

—

7.79

—

Coronary revascularization (ANGIO or CABG)

209

1310

1.11

0.79

1.3

1.2

8.12

7.66

mmol/l

1.11

149

920

Exposure to excessive heat of man-made origin

0.00

0.79

0.0

1.2

—

7.52

—

Chloasma

0.00

0.79

0.0

1.5

—

7.00

—

Histrionic personality disorder

0.00

0.79

0.0

1.4

—

7.52

—

Injury of nerves and spinal cord at thorax level

0.00

0.79

0.0

1.2

—

7.88

—

Marfan's syndrome

0.00

0.79

0.0

1.3

—

7.49

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

647

4663

0.94

0.79

1.3

7.41

7.03

mmol/l

2.17

484

3340

Other disorders of fluid, electrolyte and acid-base balance

100

1120

0.86

0.79

1.2

8.24

7.64

mmol/l

1.09

792

Hemiplegia

190

1.37

0.79

1.2

1.4

7.23

7.38

mmol/l

0.10

135

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.2

—

8.65

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

265

2418

1.10

0.79

1.5

1.4

7.25

6.67

mmol/l

2.48

204

1727

Myopia

837

0.83

0.78

1.4

1.5

6.86

6.91

mmol/l

0.06

597

GI-bleeding

108

1246

0.87

0.78

1.2

7.82

7.55

mmol/l

0.36

883

Disorders of optic nerve and visual pathways

474

0.78

1.2

1.4

6.48

7.21

mmol/l

0.89

340

Bronchitis, not specified as acute or chronic

357

1.26

0.78

1.3

7.16

7.15

mmol/l

0.01

263

Hidradenitis suppurativa

208

1.35

0.78

1.2

1.4

7.32

7.12

mmol/l

0.13

149

Postmenopausal bleeding

138

664

1.14

0.77

1.2

7.74

7.64

mmol/l

0.12

485

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

650

0.81

0.77

1.1

1.2

7.64

7.75

mmol/l

0.10

444

Nonsuppurative otitis media

168

1626

0.89

0.77

1.6

6.71

6.53

mmol/l

0.33

113

1132

Injury of muscle and tendon at shoulder and upper arm level

186

1669

1.12

0.77

1.2

7.42

7.58

mmol/l

0.25

132

1208

Conductive hearing loss, unspecified

376

1.25

0.77

1.3

7.85

7.15

mmol/l

0.56

271

Impacted teeth

187

1562

1.12

0.77

1.4

1.6

6.18

6.43

mmol/l

0.94

134

1076

Retinal vascular occlusion

367

1.26

0.77

1.2

1.3

8.37

7.77

mmol/l

0.54

262

Surgical ablation of atrial fibrillation

0.00

0.77

0.0

1.1

—

7.25

—

Use of antiglaucoma preparations and miotics

217

1.34

0.76

1.1

1.2

7.66

mmol/l

0.00

144

Iron deficiency anaemia

188

2070

0.90

0.76

1.3

7.20

7.38

mmol/l

0.32

126

1468

Melanoma in situ of lower limb, including hip

0.00

0.76

0.0

1.3

—

7.66

—

Dacryoadenitis

0.00

0.76

0.0

1.3

—

7.56

—

Cervicocranial syndrome

521

1.21

0.76

1.2

1.3

7.02

7.28

mmol/l

0.28

376

Hypothermia

1.71

0.76

1.2

1.3

7.24

7.44

mmol/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

108

748

0.86

0.76

1.2

1.1

7.36

7.58

mmol/l

0.28

519

Benign leiomyoma with endometriosis

714

0.82

0.76

1.2

1.3

7.13

7.48

mmol/l

0.41

511

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

963

0.85

0.75

1.3

1.4

6.78

7.02

mmol/l

0.36

701

Haemangioma, any site

359

1.26

0.75

1.6

1.3

7.51

7.28

mmol/l

0.17

266

Abnormal findings on diagnostic imaging of other body structures

540

1.21

0.75

1.3

7.18

7.48

mmol/l

0.36

392

Non-small cell lung cancer

449

0.78

0.75

1.1

1.2

8.23

7.70

mmol/l

0.30

324

Galactorrhea

1.68

0.75

1.6

7.91

7.12

mmol/l

—

Cardiomyopathy

680

0.82

0.75

1.1

1.2

8.11

7.66

mmol/l

0.43

486

Bilateral sagittal split ramus osteotomy operation

201

1.35

0.74

1.2

1.4

7.04

7.12

mmol/l

0.04

143

Diseases of tongue

262

1.30

0.74

1.2

1.3

6.30

7.32

mmol/l

1.40

192

Injury of nerves at wrist and hand level

158

1.40

0.74

1.2

1.4

7.99

7.07

mmol/l

0.65

111

Other specified/unspecified inflammatory spondylopathies

271

1.30

0.74

1.3

1.4

6.89

6.97

mmol/l

0.06

196

Melanocytic naevi

171

1907

0.90

0.74

1.3

1.4

6.72

7.09

mmol/l

1.09

127

1365

Malaise and fatigue

250

2281

0.91

0.74

1.3

6.83

7.22

mmol/l

1.27

182

1590

Other diseases of stomach and duodenum

220

0.68

0.74

1.2

1.3

6.78

7.64

mmol/l

—

159

Parkinson's disease

448

0.78

0.74

1.4

1.2

8.04

7.79

mmol/l

0.21

317

Other and unspecified rosacea

378

1.25

0.74

1.3

7.70

7.45

mmol/l

0.15

280

Lichen sclerosus et atrophicus

405

1.24

0.74

1.1

1.3

6.94

7.53

mmol/l

0.77

286

Other viral diseases, not elsewhere classified

1076

0.86

0.74

1.3

1.4

6.74

7.02

mmol/l

0.44

786

Other and unspecified nonorganic psychotic disorders

140

1239

1.13

0.74

1.3

1.4

8.31

6.92

mmol/l

4.05

102

913

Chalazion

578

1.20

0.74

1.4

1.3

6.47

7.22

mmol/l

1.71

423

Schizophrenia or delusion

221

2007

1.10

0.74

1.3

8.22

7.06

mmol/l

4.47

153

1476

Other noninflammatory disorders of uterus, except cervix

115

683

1.15

0.74

1.2

7.28

7.53

mmol/l

0.40

501

Endovascular or surgical operations to intracerebral aneurysms

243

0.70

0.74

1.3

1.2

7.88

7.55

mmol/l

0.13

175

Ischaemic Stroke, excluding all haemorrhages

206

1721

0.90

0.74

1.3

1.2

7.63

7.72

mmol/l

0.12

147

1205

Major anomalies of jaw size

133

1.44

0.74

1.3

1.4

6.95

7.55

mmol/l

0.39

Lichen planus, including avohilmo

781

1.17

0.74

1.2

7.87

7.40

mmol/l

0.50

578

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

334

0.75

0.73

1.1

1.2

8.11

7.96

mmol/l

0.07

228

Other fall from one level to another

142

1258

1.13

0.73

1.3

1.4

7.11

7.08

mmol/l

0.04

101

909

Hypertrophic disorders of skin

325

1.27

0.73

1.2

1.4

6.46

6.93

mmol/l

0.41

231

Other benign neoplasms of connective and other soft tissue

460

1.22

0.73

1.4

1.3

6.68

7.42

mmol/l

1.20

340

Parkinson's disease, strict definition

402

0.77

0.73

1.5

1.2

8.06

7.77

mmol/l

0.23

284

Pleural effusion

480

0.79

0.73

1.3

1.2

8.30

7.55

mmol/l

0.58

340

Unspecified mental disorder

299

2755

1.09

0.73

1.3

1.4

7.86

7.02

mmol/l

3.63

198

2011

Diagnoses used for exclusion with ILD

1088

0.86

0.73

1.2

7.42

7.53

mmol/l

0.12

792

Chronic laryngitis and laryngotracheitis

612

0.82

0.73

1.2

1.3

7.15

7.38

mmol/l

0.22

456

Infectious mononucleosis

677

0.82

0.72

1.4

1.5

6.19

6.66

mmol/l

1.17

477

Other congenital malformations of peripheral vascular system

1.68

0.72

1.8

1.5

8.32

6.99

mmol/l

—

Sensorineural hearing loss

411

2680

1.07

0.72

1.2

7.85

7.45

mmol/l

1.48

280

1939

Early lumbar disc prolapse, operated

681

1.18

0.72

1.3

6.46

6.97

mmol/l

1.05

499

Melanoma in situ of trunk

1.76

0.71

1.4

1.2

8.23

7.90

mmol/l

—

Hydronephrosis

480

1.21

0.71

1.4

1.3

7.26

7.42

mmol/l

0.14

348

Other disorders of the musculoskeletal system and connective tissue

621

0.82

0.71

1.2

6.93

7.39

mmol/l

0.48

463

Oesophageal obstruction

109

1.47

0.71

1.2

9.13

7.81

mmol/l

0.47

Maltreatment syndromes

318

1.26

0.70

1.5

7.12

7.05

mmol/l

0.05

226

Viral hepatitis

377

0.77

0.70

1.2

1.3

7.29

6.91

mmol/l

0.20

274

Benign neoplasm: Skin of trunk

160

1.38

0.70

1.3

1.4

7.52

7.45

mmol/l

0.02

111

Deviated nasal septum

194

1755

1.11

0.70

1.2

7.29

7.36

mmol/l

0.11

150

1276

Other disorders of gingiva or/and edentulous alveolar ridge

212

1.33

0.70

1.6

1.3

7.41

7.28

mmol/l

0.06

151

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

814

1.16

0.70

1.7

1.5

6.53

6.68

mmol/l

0.23

576

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

554

0.81

0.70

1.2

9.86

7.59

mmol/l

2.71

410

Tongue abnormality

221

1.32

0.70

1.2

1.3

6.55

7.50

mmol/l

1.03

159

External causes of morbidity and mortality

652

3090

1.06

0.69

1.4

7.18

6.92

mmol/l

1.18

471

2192

Panniculitis affecting regions of neck and back

169

1.37

0.69

1.2

1.4

7.78

7.25

mmol/l

0.47

117

Autism

118

1.45

0.69

1.2

1.6

6.67

6.97

mmol/l

0.16

Speech and linguistic disorders

457

0.80

0.69

1.4

1.6

6.80

6.62

mmol/l

0.17

316

Benign leiomyoma with endometriosis

706

0.83

0.69

1.2

7.13

7.58

mmol/l

0.57

517

Other/unspecified rheumatoid arthritis

454

0.79

0.69

1.3

8.44

7.59

mmol/l

0.58

327

Depression medications

345

1608

1.08

0.69

1.4

1.5

6.96

6.17

mmol/l

4.11

248

1118

Dislocation, sprain and strain of joints and ligaments of elbow

328

1.25

0.69

1.4

7.77

7.05

mmol/l

0.61

242

Asthma, hospital admission 2, infections

381

3496

1.07

0.69

1.4

1.3

7.17

7.07

mmol/l

0.23

274

2495

Asthma-related infections

381

3496

1.07

0.69

1.4

1.3

7.17

7.07

mmol/l

0.23

274

2495

Retinal vascular disorders

373

1.24

0.69

1.2

1.3

8.37

7.76

mmol/l

0.54

265

Contusion of other and unspecified parts of foot

275

1.28

0.68

1.5

6.57

6.87

mmol/l

0.25

192

Irritable bowel syndrome

192

1741

1.10

0.68

1.3

1.4

6.74

7.11

mmol/l

0.95

143

1253

Codeine

833

4363

1.05

0.68

1.4

7.28

6.95

mmol/l

2.07

643

3052

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

401

1.22

0.68

1.2

1.3

8.22

7.42

mmol/l

0.62

294

Acute pancreatitis

823

0.85

0.67

1.3

1.2

7.91

7.52

mmol/l

0.39

604

Persons encountering health services for specific procedures and health care

830

4903

1.05

0.67

1.3

7.37

7.01

mmol/l

2.62

629

3493

Schizophrenia, schizotypal and delusional disorders

220

2010

1.10

0.67

1.3

8.24

7.05

mmol/l

4.63

152

1478

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.54

0.67

1.2

8.75

7.61

mmol/l

—

Vascular diseases of the intestine

0.54

0.67

1.0

1.3

7.58

7.17

mmol/l

—

Benign neoplasm of brain and other parts of central nervous system

267

1.28

0.67

1.2

1.3

6.62

7.61

mmol/l

1.87

190

Cerebral cysts

276

1.27

0.66

1.3

1.4

7.42

7.15

mmol/l

0.16

196

Unstable angina pectoris

155

1152

1.12

0.66

1.2

8.06

7.75

mmol/l

0.44

111

794

Cervicalgia

121

1071

1.13

0.66

1.2

1.3

7.08

7.31

mmol/l

0.41

773

Foreign body on external eye

734

1.16

0.66

1.2

7.58

7.21

mmol/l

0.53

541

Oter anti-inflammatory and antirheumatic agents, non-steroids

120

586

1.14

0.66

1.2

7.40

7.42

mmol/l

0.02

401

Skin changes due to chronic exposure to nonionizing radiation

132

1111

1.12

0.66

1.2

7.41

8.00

mmol/l

1.14

750

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

114

790

0.88

0.66

1.2

1.1

7.44

7.54

mmol/l

0.11

552

Secondary parkinsonism

1.55

0.65

1.3

7.21

7.42

mmol/l

—

Injuries to unspecified part of trunk, limb or body region

412

1.22

0.65

1.1

1.4

7.06

7.25

mmol/l

0.20

303

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

102

1161

0.88

0.65

1.4

7.69

6.91

mmol/l

1.80

846

Chronic periodontitis, complicated

372

0.78

0.65

1.1

1.2

6.49

7.41

mmol/l

0.89

275

Mixed and other personality disorders

504

1.19

0.65

1.3

1.4

7.31

6.91

mmol/l

0.49

369

Benign neoplasm: Choroid

215

1.31

0.65

1.3

6.59

7.69

mmol/l

1.99

151

Autism spe, excluding more controls

120

1.42

0.65

1.2

1.6

6.67

6.77

mmol/l

0.05

Congenital deformities of feet

120

1.42

0.65

1.2

1.5

6.48

6.93

mmol/l

0.48

Generalized epilepsy

233

1.29

0.64

1.2

1.4

7.29

6.98

mmol/l

0.25

161

Other and unspecified visual disturbances

422

1.21

0.64

1.4

1.3

7.22

7.24

mmol/l

0.02

305

Kela-code for severe mental illness

260

2399

1.08

0.64

1.3

7.94

7.06

mmol/l

3.61

183

1765

Coxarthrosis [arthrosis of hip](FG)

280

1871

1.08

0.64

1.2

7.87

7.59

mmol/l

0.66

183

1350

Acne

796

0.85

0.64

1.5

1.6

6.79

6.50

mmol/l

0.48

561

Cardiomyopathy (excluding other)

493

0.81

0.64

1.2

8.05

7.63

mmol/l

0.36

345

Certain infectious and parasitic diseases

823

4316

0.95

0.64

1.3

1.4

7.18

6.96

mmol/l

1.14

629

3064

Anxiety disorders

732

4943

1.05

0.64

1.4

7.13

6.98

mmol/l

0.63

527

3562

Seborrhoeic keratosis

872

0.86

0.64

1.1

1.2

7.04

7.70

mmol/l

1.33

634

Cervical root disorders

1.74

0.64

1.0

1.1

6.30

7.84

mmol/l

—

Personality disorders

194

2127

0.91

0.64

1.4

7.32

6.81

mmol/l

1.64

145

1545

Other peripheral vascular diseases

348

0.77

0.63

1.4

1.3

6.78

7.36

mmol/l

0.71

253

Other disorders of bone

136

1217

1.12

0.63

1.3

7.01

7.17

mmol/l

0.24

101

896

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

332

0.77

0.63

1.5

1.6

6.38

6.58

mmol/l

0.12

231

Other extrapyramidal and movement disorders in other diseases

988

0.87

0.63

1.3

7.30

7.51

mmol/l

0.25

718

Traumatic subdural haemorrhage

375

0.79

0.63

1.2

7.62

7.92

mmol/l

0.21

252

Corneal ulcer

1009

0.87

0.63

1.4

1.3

6.81

7.18

mmol/l

0.66

741

Other and unspecified disorders of vitreous body

191

1731

1.10

0.63

1.2

7.31

7.64

mmol/l

0.78

138

1259

Melanocytic naevi, other sites/unspecified

387

1.22

0.63

1.3

6.96

7.18

mmol/l

0.23

281

Sudden idiopathic hearing loss

387

1.22

0.63

1.3

8.04

7.26

mmol/l

0.83

283

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

535

0.82

0.62

1.3

7.17

7.63

mmol/l

0.52

383

Other specified/unspecified bacterial intestinal infections

243

1.28

0.62

1.2

1.3

7.10

7.49

mmol/l

0.36

174

Early onset COPD

1019

0.87

0.62

1.4

1.2

7.71

7.60

mmol/l

0.11

751

Papulosquamous disorders

231

2125

1.09

0.62

1.3

7.90

7.35

mmol/l

1.49

173

1547

Melanocytic naevi of trunk

643

0.84

0.62

1.3

1.4

6.62

7.12

mmol/l

0.65

477

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

759

0.85

0.62

1.2

1.3

8.43

7.54

mmol/l

0.97

546

Extreme obesity with alveolar hypoventilation

147

1.37

0.62

1.2

1.3

8.77

7.46

mmol/l

0.81

106

Defects in the complement system

1.68

0.61

1.0

1.6

6.04

7.31

mmol/l

—

Open wound of ankle and foot

479

0.81

0.61

1.4

6.12

6.97

mmol/l

1.58

359

Hernia

630

4062

1.05

0.61

1.3

7.25

7.22

mmol/l

0.08

481

2923

Other diseases of peritoneum

182

1.32

0.61

1.3

7.59

7.50

mmol/l

0.04

130

Endometriosis diagnosis and infertility diagnosis occurring together

796

1.15

0.61

1.4

6.63

6.92

mmol/l

0.58

565

Tobacco use

262

1.26

0.61

1.6

1.4

7.32

7.21

mmol/l

0.07

187

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

643

3734

1.05

0.61

1.3

10.40

6.53

mmol/l

66.23

473

2729

Congenital malformations of ovaries, fallopian tubes and broad ligaments

412

0.80

0.61

1.5

7.13

6.88

mmol/l

0.19

294

Hereditary hypogammaglobulinemia

0.00

0.61

0.0

1.3

—

7.74

—

Hypothyroidism, autoimmune, DX-based

0.00

0.61

0.0

1.6

—

7.14

—

Other proliferative retinopathy

0.00

0.61

0.0

1.2

—

8.62

—

Chromophobe cell carcinoma of kidney

0.00

0.61

0.0

1.2

—

7.45

—

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.00

0.61

0.0

1.2

—

7.62

—

Hydrocephalus in other diseases

0.00

0.60

0.0

1.1

—

7.33

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.60

0.0

1.1

—

7.22

—

Phlebitis and thrombophlebitis (not including DVT)

121

1079

1.12

0.60

1.4

1.2

6.80

7.43

mmol/l

1.71

798

Injuries involving multiple body regions

165

1.34

0.60

1.2

1.4

7.59

7.22

mmol/l

0.19

110

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.60

0.0

1.1

—

8.45

—

Any mental disorder

858

4486

0.96

0.60

1.3

7.29

7.02

mmol/l

1.53

630

3197

Melanocytic naevi, other sites/unspecified

389

1.21

0.60

1.3

1.4

6.96

7.38

mmol/l

0.49

282

Wide developmental disorders

139

1.37

0.60

1.3

1.6

6.46

6.85

mmol/l

0.24

Renal agenesis and other reduction defects of kidney

0.00

0.60

0.0

1.7

—

7.17

—

Traumatic amputation of wrist and hand

139

1.37

0.60

1.3

1.2

7.66

7.18

mmol/l

0.35

108

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

218

2342

0.92

0.60

1.4

1.5

7.08

6.62

mmol/l

1.43

154

1675

Selective deficiency of immunoglobulin A [IgA]y

0.00

0.60

0.0

1.3

—

7.66

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.1

—

7.68

—

Disorders of other and unspecified cranial nerves

0.00

0.59

0.0

1.2

—

7.61

—

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.1

—

7.51

—

Sequelae of poliomyelitis

0.00

0.59

0.0

1.2

—

7.54

—

Vocal cord dysfunction

671

1.15

0.59

1.3

7.06

6.46

mmol/l

1.25

496

Benign neoplasm: Rectum/anal canal icd-9

0.00

0.59

0.0

1.4

—

7.09

—

Motorcycle rider injured in other and unspecified transport accidents

272

1.25

0.59

1.3

1.4

6.36

6.94

mmol/l

0.53

193

Benign neoplasm of ovary

865

0.87

0.59

1.3

6.75

7.44

mmol/l

1.61

622

Fissure and fistula of anal and rectal regions

146

1318

1.11

0.59

1.4

1.3

7.44

7.40

mmol/l

0.05

104

956

Psoriasis (vulgaris), strict definition

131

1.38

0.59

1.4

1.3

7.71

7.34

mmol/l

0.13

Gingival hyperplasia

131

1.38

0.59

1.6

1.3

7.68

7.19

mmol/l

0.21

Pulmonary embolism

105

1183

0.89

0.59

1.2

8.60

7.56

mmol/l

1.74

864

Disorders of breast

359

3120

1.07

0.59

1.4

7.11

7.01

mmol/l

0.25

287

2237

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.59

0.0

1.7

—

7.39

—

Benign neoplasm: Hypopharynx

0.00

0.59

0.0

1.2

—

7.59

—

Other disorders of amino-acid metabolism

0.00

0.58

0.0

1.3

—

7.83

—

Colorectal adenocarcinoma

628

0.84

0.58

1.1

1.2

7.64

7.92

mmol/l

0.27

445

Melanoma in situ of lower limb, including hip

0.00

0.58

0.0

1.2

—

7.60

—

Benign neoplasm: Skin of trunk

166

1.33

0.58

1.3

1.4

7.52

7.76

mmol/l

0.08

118

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.58

0.0

1.2

—

8.85

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.58

0.0

1.3

—

7.95

—

Pulmonary heart disease

105

1182

0.89

0.58

1.2

8.60

7.56

mmol/l

1.73

863

Benign neoplasm of colon, rectum, anus and anal canal

292

2454

1.07

0.58

1.2

7.41

7.60

mmol/l

0.43

215

1756

Viral pneumonia

595

0.84

0.58

1.4

1.3

6.77

7.24

mmol/l

0.69

426

Cardiac murmurs and other cardiac sounds

477

1.18

0.58

1.4

1.5

7.16

6.91

mmol/l

0.30

328

Hyperkinetic disorders, excluding more controls

819

0.87

0.58

1.4

1.6

6.31

6.46

mmol/l

0.24

572

Other Crohn's disease

376

0.80

0.58

1.4

6.67

6.86

mmol/l

0.14

274

Schizophrenia or delusion, excluding more controls

221

2022

1.09

0.58

1.3

8.22

6.99

mmol/l

4.92

153

1476

Parkinson's disease, including avohilmo

464

0.82

0.58

1.4

1.2

8.13

7.82

mmol/l

0.29

331

Right hemicolectomy

173

0.69

0.57

1.3

1.2

6.91

7.64

mmol/l

—

120

Benign neoplasm: Parotid gland

309

0.77

0.57

1.3

9.26

7.61

mmol/l

1.20

226

Other bursopathies

567

1.17

0.57

1.3

1.2

6.34

7.61

mmol/l

3.79

408

Melanocytic naevi

171

1872

0.91

0.57

1.3

1.4

6.72

7.04

mmol/l

0.91

127

1360

Benign lipomatous neoplasm of other sites/unspecified

328

1.22

0.57

1.1

1.3

7.44

7.69

mmol/l

0.23

234

Anxious personality disorder

115

1.40

0.57

1.3

1.5

7.93

7.16

mmol/l

0.42

Other diseases of biliary tract

275

0.76

0.57

1.3

8.35

7.41

mmol/l

0.45

195

Neurotic, stress-related and somatoform disorders

724

4923

1.05

0.57

1.4

7.14

6.97

mmol/l

0.76

522

3547

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

238

1.26

0.57

1.2

1.3

8.05

7.26

mmol/l

0.67

170

Other menopausal disorders

156

814

1.11

0.57

1.2

1.3

7.20

7.40

mmol/l

0.33

120

610

Other ulcerative colitis

283

1.24

0.56

1.3

1.4

7.42

7.23

mmol/l

0.13

205

Fall on and from ladder

274

1.24

0.56

1.3

1.2

7.52

7.36

mmol/l

0.10

202

Haemangioma, any site

374

1.21

0.56

1.6

1.3

7.51

7.34

mmol/l

0.12

280

Bronchiectasis

247

1.26

0.56

1.5

1.3

6.90

7.65

mmol/l

0.76

167

Emergency coronary revascularization (for ACS)

226

1498

1.08

0.56

1.2

8.19

7.71

mmol/l

1.16

159

1042

Other heart diseases, wide

730

4331

1.05

0.56

1.2

1.3

7.22

7.07

mmol/l

0.68

557

3116

Polyarthritis, unspecified

141

1.35

0.56

1.3

6.43

7.40

mmol/l

0.67

107

Adenocarcinoma and ductal carcinoma of pancreas

0.58

0.56

1.2

8.75

7.34

mmol/l

—

Hernia of abdominal wall, postoperative

105

934

1.13

0.56

1.4

1.2

7.23

7.45

mmol/l

0.25

656

Asthma and allergy

112

988

1.12

0.56

1.5

6.27

6.66

mmol/l

0.70

678

Benign neoplasm of other and unspecified female genital organs

185

1.30

0.56

1.4

7.47

7.39

mmol/l

0.05

135

Persistent mood disorders

105

1178

0.89

0.56

1.3

1.4

7.38

7.04

mmol/l

0.53

858

Other disorders of breast

753

0.86

0.56

1.4

7.86

7.04

mmol/l

1.22

539

Duodenal ulcer

341

0.79

0.56

1.2

8.74

7.60

mmol/l

0.58

242

Acute sinusitis

394

3463

1.06

0.56

1.4

7.04

6.98

mmol/l

0.16

293

2457

Enterocolitis due to Clostridium difficile

363

0.80

0.55

1.2

1.3

7.14

7.61

mmol/l

0.36

264

Malignant melanoma of skin

407

0.81

0.55

1.2

1.3

7.02

7.59

mmol/l

0.51

299

Disorders of sclera, cornea, iris and ciliary body

313

3341

0.94

0.55

1.4

1.3

7.07

7.18

mmol/l

0.28

231

2427

Embedded teeth, including avohilmo

728

1.14

0.55

1.6

6.66

6.62

mmol/l

0.05

505

Unspecified abortion

275

1.24

0.55

1.3

1.2

6.92

7.12

mmol/l

0.14

203

Conductive and sensorineural hearing loss

451

2954

1.06

0.55

1.2

1.3

7.82

7.38

mmol/l

1.70

310

2143

Otalgia

366

1.21

0.55

1.4

6.99

7.12

mmol/l

0.13

266

Fracture of lower leg, including ankle

303

3223

0.94

0.55

1.3

7.48

7.20

mmol/l

0.78

219

2334

Spermatocele

239

1.26

0.55

1.1

1.2

7.02

7.65

mmol/l

0.58

181

Intermittent heterotropia

348

1.21

0.55

1.5

6.89

6.73

mmol/l

0.16

233

Dermatographic urticaria

384

0.81

0.55

1.3

1.4

6.88

7.13

mmol/l

0.17

274

Disorders of puberty, all

1.47

0.54

1.5

1.6

5.20

6.91

mmol/l

—

FESS (DNB20)

644

0.85

0.54

1.3

7.79

7.25

mmol/l

0.29

485

Other and/or unspecified nontoxic goitre

321

1.22

0.54

1.2

7.25

7.33

mmol/l

0.06

232

Asthma and allergy, excluding more controls

112

991

1.12

0.54

1.5

1.4

6.27

6.63

mmol/l

0.63

679

Abscess of anal and rectal regions

413

1.19

0.54

1.4

1.3

7.66

7.17

mmol/l

0.46

305

Gout, unspecified

665

0.86

0.54

1.2

7.83

7.85

mmol/l

0.02

463

Manic episode

160

1.32

0.53

1.2

1.4

9.42

7.58

mmol/l

0.70

109

Muscle strain

160

1.32

0.53

1.3

1.4

6.74

7.36

mmol/l

0.29

112

Other complications of surgical and medical care, not elsewhere classified

441

1.18

0.53

1.4

1.3

7.08

7.20

mmol/l

0.13

327

Congenital malformations of heart and great arteries

598

1.15

0.53

1.2

1.4

6.90

6.99

mmol/l

0.07

435

Cardiomyopathies, Primary/intrinsic

470

0.83

0.53

1.2

8.09

7.66

mmol/l

0.36

333

Other metabolic disorders

693

1.14

0.53

1.3

7.44

7.20

mmol/l

0.29

523

Retinal breaks without detachment

664

0.86

0.53

1.1

1.2

6.40

7.55

mmol/l

2.58

499

Purpura and other haemorrhagic conditions

578

0.85

0.53

1.4

1.3

6.93

7.26

mmol/l

0.32

424

Specific development disorders of speech and language

251

0.76

0.53

1.5

6.47

6.66

mmol/l

0.12

170

Dizziness and giddiness

480

3699

1.05

0.53

1.3

7.09

7.22

mmol/l

0.37

333

2680

Chronic viral hepatitis

294

0.78

0.53

1.2

1.3

7.01

6.86

mmol/l

0.07

214

Emotional disorders starting during childhood or adolescence

356

1.20

0.53

1.7

1.6

7.61

6.46

mmol/l

0.90

241

Neoplasms

697

3901

0.96

0.53

1.4

7.02

6.89

mmol/l

0.45

511

2755

Abnormal blood-pressure reading, without diagnosis

178

1.30

0.53

1.3

1.4

7.40

7.46

mmol/l

0.02

131

Viral warts

545

0.84

0.53

1.4

6.89

7.00

mmol/l

0.09

388

Peritonsillar abscess

166

1522

1.09

0.52

1.3

1.4

6.61

6.87

mmol/l

0.63

120

1096

Benign neoplasm of major salivary glands

381

0.81

0.52

1.4

1.3

8.71

7.59

mmol/l

0.94

278

Appendicitis, broad definition

563

4913

1.05

0.52

1.4

1.3

7.11

7.05

mmol/l

0.17

410

3546

Diseases of appendix

566

4923

1.05

0.52

1.4

1.3

7.12

7.05

mmol/l

0.21

413

3555

Benign neoplasm: Other and unspecified parts of mouth

126

1.35

0.51

1.4

1.3

8.76

7.75

mmol/l

0.31

Atopic dermatitis, strict definition

257

2351

1.07

0.51

1.5

6.78

6.65

mmol/l

0.35

191

1676

Benign neoplasm of other and unspecified endocrine glands

536

1.16

0.51

1.3

7.66

7.41

mmol/l

0.26

398

Other disorders of skin and subcutaneous tissue, not elsewhere classified

597

0.85

0.51

1.2

1.3

6.89

7.30

mmol/l

0.47

428

Conjunctivitis (acute, non atopic)

163

1770

0.92

0.51

1.4

6.98

7.09

mmol/l

0.20

123

1278

Oral lichen ruber planus wide, hypothyreosis or thyroxin

188

1.28

0.51

1.3

7.62

7.66

mmol/l

0.02

129

Hypopituitarism

278

1.23

0.51

1.3

7.24

7.07

mmol/l

0.11

209

Contact with heat and hot substances

242

1.24

0.51

1.3

1.4

6.24

7.18

mmol/l

1.55

171

Parkinson's disease, excluding more controls

413

0.82

0.51

1.4

1.2

8.04

8.23

mmol/l

0.15

279

Benign neoplasm: Cerebral meninges

324

1.21

0.50

1.2

1.3

7.49

7.50

mmol/l

0.00

231

Gluteal tendinitis

144

1.32

0.50

1.2

1.3

7.06

7.41

mmol/l

0.19

100

Malignant melanoma, excluding all cancers (controls excluding all cancers)

671

0.86

0.50

1.3

1.2

7.22

7.56

mmol/l

0.44

471

DVT of lower extremities and pulmonary embolism

169

1831

0.92

0.50

1.2

8.03

7.52

mmol/l

0.98

118

1313

Triptan medication for migraine, min. 3 purchases

513

3858

1.05

0.50

1.4

6.76

6.81

mmol/l

0.16

387

2791

Chronic hepatitis, not elsewhere classified

153

1.31

0.50

1.6

1.4

7.88

7.49

mmol/l

0.16

105

Superficial injury of head

106

1178

0.90

0.50

1.3

6.89

7.20

mmol/l

0.66

848

Unspecified lump in breast

829

1.12

0.50

1.4

1.3

7.35

7.27

mmol/l

0.07

595

Presence of cardiac and vascular implants and grafts

187

1305

1.08

0.50

1.1

1.2

8.15

7.68

mmol/l

0.88

135

902

Emotional disorders and disorders of social functioning with onset specific to childhood

384

1.19

0.50

1.6

1.7

7.60

6.47

mmol/l

1.02

262

Disorders of other endocrine glands

289

2669

1.07

0.49

1.4

7.25

7.04

mmol/l

0.46

210

1908

Dental caries 1 and operation codes, only avohilmo

200

928

1.08

0.49

1.4

1.3

7.05

6.87

mmol/l

0.29

134

657

Other diseases of intestine

433

0.83

0.49

1.2

1.3

7.27

7.65

mmol/l

0.27

322

Special screening examination for other diseases and disorders

422

0.83

0.49

1.5

1.4

7.85

7.11

mmol/l

0.66

308

Other diseases of intestines

866

4850

1.04

0.49

1.3

1.4

7.08

7.00

mmol/l

0.32

640

3455

Benign neoplasm: Descending colon

235

0.76

0.49

1.1

1.3

7.45

7.83

mmol/l

0.16

166

Cyst of kidney

225

1.25

0.49

1.3

6.38

7.85

mmol/l

1.77

163

Thyroiditis

362

1.19

0.49

1.3

1.4

6.18

7.20

mmol/l

1.53

254

Chondropathies

887

1.12

0.49

1.3

6.94

7.16

mmol/l

0.29

659

145

1246

1.10

0.49

1.2

7.34

7.91

mmol/l

1.20

104

855

Allergic urticaria

454

0.84

0.49

1.4

6.68

6.99

mmol/l

0.30

324

Benign neoplasm of major salivary glands

378

0.82

0.49

1.4

1.3

8.71

7.39

mmol/l

1.18

279

Benign neoplasm of ovary

849

0.88

0.48

1.3

6.75

7.45

mmol/l

1.63

618

Post-traumatic wound infection, not elsewhere classified

109

0.64

0.48

1.0

1.4

5.20

7.41

mmol/l

—

Coagulation defects, purpura and other haemorrhagic conditions

986

0.89

0.48

1.4

6.93

7.21

mmol/l

0.36

718

Presbyopia

262

1.22

0.48

1.2

6.57

7.52

mmol/l

1.43

194

Other and unspecified injuries of thorax

1.45

0.48

1.2

1.4

6.56

7.36

mmol/l

—

Superficial injury of forearm

521

1.15

0.48

1.3

1.4

7.14

6.84

mmol/l

0.41

380

Haemangioma and lymphangioma, any site

400

1.18

0.48

1.6

1.3

7.51

7.26

mmol/l

0.18

294

Primary open-angle glaucoma

112

986

1.11

0.48

1.2

7.94

7.91

mmol/l

0.03

676

Cerebral palsy and other paralytic syndromes

493

1.16

0.48

1.3

7.45

7.16

mmol/l

0.23

366

Lichen simplex chronicus and prurigo

235

1.24

0.48

1.2

1.3

6.98

7.33

mmol/l

0.20

181

TMD muscular pain linked with fibromyalgia

1.50

0.48

1.3

6.70

7.50

mmol/l

—

Gastroduodenal ulcer

930

0.89

0.48

1.2

8.10

7.78

mmol/l

0.28

662

Disorders of calcium metabolism

199

1.26

0.48

1.2

1.3

7.74

7.53

mmol/l

0.14

145

Ethmoidectomy

667

0.87

0.47

1.3

7.75

7.25

mmol/l

0.27

500

Malignant neoplasm of thyroid gland

290

1.21

0.47

1.1

1.3

7.69

7.30

mmol/l

0.37

211

Motor disorders

1.49

0.47

1.3

1.7

8.41

6.62

mmol/l

—

Coronary artery bypass grafting

678

0.89

0.47

1.1

1.2

8.71

7.84

mmol/l

1.05

454

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

401

1.17

0.47

1.4

7.09

7.15

mmol/l

0.04

295

Other predominantly sexually transmitted diseases, not elsewhere classified

127

1392

0.91

0.47

1.5

7.34

6.71

mmol/l

1.29

1008

Isolated proteinuria with specified morphological lesion

1.47

0.47

1.4

1.2

7.36

7.54

mmol/l

—

Melanoma in situ of trunk

1.47

0.47

1.4

1.3

8.23

7.65

mmol/l

—

Panic disorder

110

1214

0.90

0.47

1.4

1.5

6.93

6.63

mmol/l

0.48

875

Other disorders of penis

332

0.81

0.46

1.1

1.2

7.10

7.53

mmol/l

0.35

248

LSIL lesion of the cervix uteri

898

0.89

0.46

1.5

6.90

6.80

mmol/l

0.10

638

Visual disturbances and blindness

268

2851

0.94

0.46

1.4

1.3

7.38

7.19

mmol/l

0.42

200

2047

Poisoning by medicine

140

1526

0.92

0.46

1.4

7.14

6.87

mmol/l

0.51

105

1113

Specific developmental disorder of motor function

1.44

0.46

1.3

1.6

8.41

6.60

mmol/l

—

Hypoplasia of dental enamel , including avohilmo

115

0.68

0.46

2.0

1.6

6.44

6.67

mmol/l

—

Ulcer of vagina/vulva

129

1.32

0.46

1.2

1.6

6.24

7.08

mmol/l

0.72

Habit and impulse disorders

0.60

0.46

1.8

1.4

7.28

7.24

mmol/l

—

Erysipelas

258

2506

0.94

0.46

1.2

8.05

7.40

mmol/l

1.98

188

1790

Motor disorders, excluding more controls

1.43

0.46

1.3

1.8

8.41

6.63

mmol/l

—

Injury, poisoning and certain other consequences of external causes

525

2514

1.05

0.45

1.4

7.09

6.93

mmol/l

0.55

381

1749

Localized swelling, mass and lump of skin and subcutaneous tissue

157

1701

0.92

0.45

1.4

1.3

7.20

7.38

mmol/l

0.33

124

1223

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

751

1.12

0.45

1.7

1.5

6.29

6.55

mmol/l

0.58

527

Fenamates

106

790

0.90

0.45

1.3

1.5

6.97

6.91

mmol/l

0.08

541

Complications of surgical and medical care, not elsewhere classified

649

4839

0.96

0.45

1.3

7.36

7.09

mmol/l

1.32

479

3477

Benign neoplasm of other and unspecified female genital organs

192

1.25

0.45

1.4

7.47

7.42

mmol/l

0.03

139

Alcohol-induced chronic pancreatitis

253

0.79

0.44

1.2

9.44

7.36

mmol/l

0.85

194

Parkinson's disease, strict definition, excluding more controls

366

0.83

0.44

1.5

1.1

8.06

8.20

mmol/l

0.10

241

Venous thromboembolism

241

2492

0.94

0.44

1.3

7.66

7.45

mmol/l

0.42

178

1763

Wide developmental disorders, excluding more controls

146

1.29

0.44

1.3

1.6

6.46

6.70

mmol/l

0.14

Benign neoplasm: Ascending colon

441

1.16

0.44

1.2

8.13

7.81

mmol/l

0.26

309

Benign neoplasm: Ascending colon

441

1.16

0.44

1.2

8.13

7.66

mmol/l

0.42

324

Effects of foreign body entering through natural orifice

144

1325

1.09

0.44

1.3

7.47

7.22

mmol/l

0.44

111

975

Hypo-osmolality and hyponatraemia

554

0.86

0.44

1.2

8.30

7.62

mmol/l

0.76

395

Primary open-angle glaucoma, strict

826

1.11

0.44

1.2

8.14

7.93

mmol/l

0.28

564

Contact with machinery

460

1.15

0.44

1.1

1.2

7.79

7.39

mmol/l

0.47

343

Ulcerative ileocolitis

208

0.77

0.44

1.4

1.3

7.93

7.21

mmol/l

0.33

145

Mixed conductive and sensorineural hearing loss

448

0.85

0.43

1.1

1.3

8.20

7.53

mmol/l

0.44

318

Pain associated with micturition

526

1.14

0.43

1.2

1.3

6.87

7.30

mmol/l

0.53

380

Cystitis

644

4091

0.96

0.43

1.4

7.01

6.96

mmol/l

0.17

499

2876

Bicipital tendinitis

184

1.25

0.43

1.0

1.2

8.46

7.60

mmol/l

0.33

131

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

299

2929

0.95

0.43

1.2

1.3

7.25

7.49

mmol/l

0.56

203

2106

Conduction disorders

111

1013

0.91

0.43

1.2

8.07

7.57

mmol/l

0.68

705

Other bacterial intestinal infections

777

0.89

0.43

1.2

1.3

6.99

7.42

mmol/l

0.68

566

Hypertrophy of breast in women and men

127

1164

1.09

0.43

1.3

7.04

7.13

mmol/l

0.13

102

853

Biological medication for rheuma

987

0.90

0.43

1.5

1.4

6.79

7.04

mmol/l

0.34

722

Malignant neoplasm of corpus uteri

239

1.22

0.42

1.1

1.2

8.40

7.93

mmol/l

0.25

163

Sicca syndrome [Sjögren]

371

0.83

0.42

1.3

6.44

7.46

mmol/l

0.77

277

Poisoning by drugs, medicaments and biological substances

156

1684

0.93

0.42

1.4

7.09

6.89

mmol/l

0.37

116

1219

Benign neoplasm: Spinal meninges

1.57

0.42

1.2

10.86

7.53

mmol/l

—

Hydrocele

359

1.17

0.42

1.2

6.51

7.78

mmol/l

2.22

268

Myalgia

151

1396

1.08

0.42

1.4

6.88

7.13

mmol/l

0.50

106

996

Postpartum haemorrhage due to anatomy

136

1475

0.92

0.42

1.7

1.6

6.35

6.29

mmol/l

0.13

1045

Ovarian hyperstimulation (induction)

149

1.28

0.42

1.6

1.5

6.92

6.66

mmol/l

0.16

102

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

333

3492

0.95

0.42

1.2

1.3

7.47

7.22

mmol/l

0.60

225

2530

Use of pramipexole

891

0.90

0.42

1.3

1.2

7.32

7.59

mmol/l

0.27

648

Paroxysmal tachycardia

138

1074

1.09

0.42

1.2

1.3

7.48

6.99

mmol/l

0.99

101

764

Other and unspecified disorders of white blood cells

149

1.28

0.42

1.2

1.3

6.60

7.53

mmol/l

0.70

105

Postprocedural endocrine and metabolic disorders, not elsewhere classified

632

1.13

0.42

1.3

7.22

7.24

mmol/l

0.02

477

Myocardial infarction, strict

209

1426

1.07

0.41

1.2

8.03

7.67

mmol/l

0.79

144

1006

Early lumbar disc prolapse operation

727

1.12

0.41

1.3

1.4

6.46

7.02

mmol/l

1.21

549

Relapsing polychondritis

0.00

0.41

0.0

1.2

—

8.22

—

Bell's palsy

563

0.87

0.41

1.4

1.3

7.28

7.26

mmol/l

0.02

424

Benign neoplasm: Extrahepatic bile ducts

0.00

0.41

0.0

1.3

—

7.62

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.41

0.0

1.1

—

7.86

—

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.3

—

8.65

—

Actinomycosis

0.00

0.41

0.0

1.3

—

7.31

—

Benign neoplasm: Spinal meninges

1.52

0.41

1.2

10.86

7.51

mmol/l

—

Other inflammation of vagina/vulva

261

0.80

0.41

1.3

1.5

6.23

6.86

mmol/l

0.68

184

Cachexia

0.00

0.41

0.0

2.1

—

6.57

—

Pneumonia due to Haemophilus influenzae

0.00

0.41

0.0

1.3

—

7.60

—

Disorders of purine and pyrimidine metabolism

0.00

0.41

0.0

1.1

—

7.59

—

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

8.02

—

Intracranial injury

332

3375

0.95

0.41

1.4

1.3

7.27

7.12

mmol/l

0.44

235

2410

Oral lichen ruber planus, including avohilmo

240

1.21

0.41

1.2

1.3

7.32

7.51

mmol/l

0.15

170

Mucinous and mucinous cystic tumor of rectum

0.00

0.41

0.0

1.1

—

7.26

—

Myelodysplastic syndrome

0.00

0.41

0.0

1.3

—

7.09

—

Complications following myocardial infarction

0.00

0.41

0.0

1.3

—

7.67

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

0.00

0.41

0.0

1.1

—

7.73

—

Adrenogenital disorders

0.00

0.41

0.0

1.3

—

7.27

—

Other specified/unspecified diseases of inner ear

0.00

0.41

0.0

1.1

—

8.05

—

All dysplastic lesions of the cervix uteri

216

2296

0.94

0.41

1.5

7.03

6.65

mmol/l

0.82

155

1655

Benign neoplasm of meninges

351

1.17

0.41

1.1

1.2

7.75

7.48

mmol/l

0.15

252

Explosion of other materials

0.00

0.41

0.0

1.2

—

8.71

—

Nondiabetic hypoglycaemic coma

0.00

0.41

0.0

1.3

—

7.94

—

Heart failure and antihypertensive medication

101

605

1.10

0.41

1.2

8.56

6.89

mmol/l

4.80

453

Carcinoma in situ of breast

0.00

0.41

0.0

1.2

—

6.95

—

Blindness or visual impairment, binocular

0.00

0.41

0.0

1.2

—

6.49

—

Benign neoplasm of mouth and pharynx

454

1.15

0.41

1.3

8.00

7.39

mmol/l

0.55

339

Hypersensitivity angiitis

0.00

0.41

0.0

1.1

—

7.30

—

Frontotemporal dementia

0.00

0.41

0.0

1.1

—

7.11

—

Leiomyosarcoma

0.00

0.41

0.0

1.2

—

7.09

—

Use of biperiden

213

1.22

0.40

1.3

9.21

7.33

mmol/l

1.37

160

Cramp and spasm

195

1.23

0.40

1.2

1.4

6.75

7.33

mmol/l

0.42

135

Idiopathic pulmonary fibrosis

195

1.23

0.40

1.2

7.89

7.86

mmol/l

0.01

134

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.40

0.0

1.3

—

7.64

—

Hereditary factor VIII deficiency

0.00

0.40

0.0

1.3

—

8.13

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.40

0.0

1.4

—

7.45

—

Genitourinary diseases

527

2535

1.04

0.40

1.4

1.3

7.11

6.97

mmol/l

0.44

373

1785

Ulcerative proctitis

324

1.18

0.40

1.3

1.4

7.06

7.15

mmol/l

0.06

236

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.40

0.0

1.4

—

7.50

—

Other and unspecified atrophic disorders of skin

0.00

0.40

0.0

1.7

—

7.04

—

Malignant neoplasm of floor of mouth

0.00

0.40

0.0

1.1

—

8.13

—

Carcinoma in situ of breast

0.00

0.40

0.0

1.2

—

6.90

—

Use of entacapone

0.00

0.40

0.0

1.3

—

7.27

—

Actinic keratosis

123

1073

1.09

0.40

1.2

7.50

8.02

mmol/l

0.88

723

Noninflammatory disorders of female genital tract

444

2136

1.05

0.40

1.5

7.12

6.65

mmol/l

1.97

304

1517

Hard cardiovascular diseases

436

2676

1.05

0.40

1.3

1.2

7.68

7.45

mmol/l

0.71

323

1940

Benign neoplasm: Rectum, anus and anal canal

720

1.11

0.39

1.1

1.2

7.36

7.70

mmol/l

0.32

525

Hypokalaemia

399

1.15

0.39

1.3

8.25

7.50

mmol/l

0.80

288

Erythema multiforme

1.35

0.39

1.4

1.3

5.65

7.41

mmol/l

—

Malignant neoplasm of endocrine gland

306

1.18

0.39

1.1

1.3

7.69

7.29

mmol/l

0.38

222

D07AA Corticosteroids, weak (group I)

1001

0.91

0.39

1.6

1.4

6.96

6.90

mmol/l

0.08

722

Striking against or struck by other objects

188

2007

0.94

0.39

1.3

6.94

7.07

mmol/l

0.25

121

1465

Myocardial infarction

225

1518

1.06

0.39

1.2

8.10

7.65

mmol/l

1.19

156

1083

Benign neoplasm: Parotid gland

292

0.82

0.39

1.3

9.26

7.42

mmol/l

1.39

218

malignant neoplasm of female genital organs

560

0.87

0.39

1.1

1.3

8.33

7.74

mmol/l

0.49

398

Contact urticaria

0.00

0.39

0.0

1.6

—

7.55

—

Crohn's disease of large intestine

270

0.81

0.39

1.3

1.4

6.68

7.11

mmol/l

0.24

198

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.1

—

7.84

—

Bacterial intestinal infections, IBD co-morbidities

771

0.89

0.39

1.2

1.3

6.98

7.44

mmol/l

0.73

561

Benign neoplasm: Hypopharynx

0.00

0.39

0.0

1.2

—

7.41

—

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.3

—

7.99

—

Hereditary corneal dystrophies

106

1.32

0.39

1.6

1.3

8.09

7.30

mmol/l

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

0.39

0.0

1.4

—

7.11

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

827

0.90

0.39

1.2

1.4

7.07

7.03

mmol/l

0.03

599

Complications associated with artificial fertilization

151

1.27

0.39

1.6

6.92

6.72

mmol/l

0.12

116

Vitamin deficiency, wide

178

1.24

0.38

1.3

6.97

7.02

mmol/l

0.02

125

Vitamin deficiency

178

1.24

0.38

1.3

6.97

7.02

mmol/l

0.02

125

Benign neoplasm of thyroid gland

133

1.28

0.38

1.1

1.3

6.59

7.37

mmol/l

—

Postprocedural disorders of nervous system

495

0.87

0.38

1.4

6.52

6.95

mmol/l

0.31

350

Retinoschisis and retinal cysts

1.38

0.38

1.1

8.21

7.04

mmol/l

—

Missing teeth due to accident, extraction or parodontitis

466

1.14

0.38

1.2

6.88

7.39

mmol/l

0.80

347

Benign neoplasm: Cerebral meninges

335

1.17

0.38

1.2

1.3

7.49

7.64

mmol/l

0.08

244

Foreign body entering into or through eye or natural orifice

354

1.16

0.38

1.4

1.3

7.53

7.04

mmol/l

0.39

265

Superficial injury of lower leg

159

1482

1.07

0.38

1.4

7.08

7.03

mmol/l

0.07

113

1068

Other and unspecified local infections of skin and subcutaneous tissue

401

1.15

0.38

1.3

7.53

7.16

mmol/l

0.31

295

Aneurysms, operations, SAH

674

0.89

0.37

1.3

1.2

7.44

7.50

mmol/l

0.05

496

Crohn disease

737

0.89

0.37

1.4

7.10

7.01

mmol/l

0.08

541

Vitamin B12 deficiency anaemia

355

0.84

0.37

1.3

7.40

7.73

mmol/l

0.19

250

Habitual aborter

179

1.24

0.37

2.0

1.7

5.64

6.60

mmol/l

3.71

135

Hypertrophic scar

308

1.17

0.37

1.2

1.4

6.44

7.01

mmol/l

0.50

216

Other and unspecified drugs and medicaments

364

1.16

0.37

1.5

1.3

7.15

7.24

mmol/l

0.05

262

Problems related to lifestyle

631

0.89

0.37

1.4

7.00

6.93

mmol/l

0.07

425

Benign neoplasm of middle ear and respiratory system

299

1.17

0.37

1.3

7.96

7.40

mmol/l

0.39

225

Benign neoplasm: Other and unspecified parts of mouth

134

1.27

0.37

1.4

1.3

8.76

8.11

mmol/l

0.18

Cystic kidney disease

116

0.69

0.37

1.5

1.4

7.20

7.14

mmol/l

—

Infections, IBD-co-morbidities

617

1.10

0.36

1.2

1.3

7.17

6.53

mmol/l

1.35

433

Bulimia nervosa (incl. atypical)

332

0.84

0.36

1.5

1.6

7.01

6.61

mmol/l

0.34

231

Other systemic involvement of connective tissue (FG)

144

1331

1.08

0.36

1.3

7.16

7.32

mmol/l

0.24

110

956

Crohn disease (strict definition, all UC cases excluded)

267

0.82

0.36

1.6

1.4

6.92

7.07

mmol/l

0.11

191

Hypothyroidism due to medicaments and other exogenous substances

1.47

0.36

1.2

1.1

6.87

7.14

mmol/l

—

Other noninflammatory disorders of vulva and perineum

592

1.12

0.36

1.3

1.5

6.24

6.87

mmol/l

1.49

433

Diarrhoea and gastroenteritis of presumed infectious origin

477

4502

0.96

0.36

1.3

1.4

7.19

7.00

mmol/l

0.68

353

3204

Sequelae of infectious and parasitic diseases

310

0.84

0.36

1.3

7.17

7.32

mmol/l

0.07

237

Other reaction to severe stress, and adjustment disorders

281

2953

0.95

0.36

1.4

6.98

6.80

mmol/l

0.50

208

2153

Artificial joint operation, meniscal resection

538

3450

1.04

0.36

1.3

1.2

7.40

7.41

mmol/l

0.03

402

2499

Psychiatric diseases

862

4444

0.97

0.36

1.3

7.27

7.02

mmol/l

1.38

635

3167

Other local infections of skin and subcutaneous tissue

422

1.14

0.36

1.3

7.53

7.19

mmol/l

0.29

312

Open wound of wrist and hand

269

2802

0.95

0.36

1.3

6.95

7.08

mmol/l

0.27

201

1997

Benign neoplasm: Cranial nerves

1.32

0.35

1.1

1.3

6.15

7.20

mmol/l

—

Polycystic ovarian syndrome, consortium definition

627

3656

1.03

0.35

1.4

7.21

6.78

mmol/l

3.01

461

2601

Other and unspecified glaucoma

190

0.79

0.35

1.1

1.2

8.94

7.70

mmol/l

0.70

132

685

1.10

0.35

1.2

7.98

7.97

mmol/l

0.01

449

Other specified and unspecified disorders of eye and adnexa

153

1.24

0.35

1.3

7.67

7.35

mmol/l

0.16

108

Molar incisor enamel hypoplasia

119

0.74

0.35

1.9

1.6

6.58

mmol/l

—

Acne vulgaris

628

0.89

0.35

1.5

1.6

6.76

6.51

mmol/l

0.37

438

Disorders of tooth development and eruption

301

0.84

0.35

1.4

1.5

5.91

6.73

mmol/l

1.18

217

Schizophrenia

861

1.09

0.35

1.3

8.67

7.08

mmol/l

2.78

651

Calcific aortic valvular stenosis

840

0.91

0.35

1.1

1.2

8.45

7.93

mmol/l

0.50

570

Calcific aortic valvular stenosis, operated

840

0.91

0.35

1.1

1.2

8.45

7.93

mmol/l

0.50

570

Benign neoplasm: Rectum

622

1.11

0.35

1.1

1.2

7.51

7.65

mmol/l

0.09

454

Postpartum hemorraghe, parous women as controls

317

2650

1.05

0.35

1.6

1.5

6.34

6.48

mmol/l

0.57

220

1890

Crohn disease (strict definition, require KELA, min 2 HDR)

341

0.85

0.35

1.6

1.4

7.62

6.89

mmol/l

0.53

244

Postpartum haemorrhage due to retained placenta

135

1449

0.93

0.35

1.5

1.6

6.45

6.51

mmol/l

0.10

1034

Chronic pancreatitis

469

0.87

0.35

1.2

8.99

7.40

mmol/l

1.30

341

Benign neoplasm: Descending colon

222

0.81

0.34

1.1

1.3

7.45

7.55

mmol/l

0.04

163

Gastric ulcer

606

0.89

0.34

1.1

1.2

8.05

7.75

mmol/l

0.20

433

Herpesviral [herpes simplex] infections

604

1.11

0.34

1.3

1.4

7.10

7.20

mmol/l

0.09

445

conjunctival haemorrhage

246

1.18

0.34

1.2

1.3

7.06

7.46

mmol/l

0.18

177

Benign mammary dysplasia

647

0.90

0.34

1.3

6.70

7.52

mmol/l

1.69

456

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

372

0.86

0.34

1.5

1.4

7.60

6.95

mmol/l

0.48

268

Insomnia

107

988

1.08

0.34

1.4

7.20

6.99

mmol/l

0.29

733

Operations 2 for CAVS

838

0.91

0.34

1.1

1.2

8.45

7.93

mmol/l

0.50

569

Calcific aortic valvular stenosis, diagnosis (helper)

838

0.91

0.34

1.1

1.2

8.45

7.93

mmol/l

0.50

569

Congenital malformations of breast

109

1.29

0.33

1.8

1.6

6.92

7.04

mmol/l

—

Spinal instabilities

136

1.25

0.33

1.2

1.3

6.73

7.12

mmol/l

—

Graves disease, strict definition

605

1.11

0.33

1.5

1.4

6.66

7.08

mmol/l

0.79

438

Diseases of the eye and adnexa

769

3966

0.97

0.33

1.3

1.4

6.94

6.95

mmol/l

0.01

572

2833

Cardiac arrest

180

1.20

0.33

1.2

7.95

7.55

mmol/l

0.21

124

Non-follicular lymphoma, hilmo, excluding all cancers

318

0.85

0.33

1.3

7.83

7.69

mmol/l

0.07

221

Injury of muscle and tendon at lower leg level

709

0.90

0.33

1.1

1.2

7.76

7.34

mmol/l

0.42

529

Other immunodeficiencies

1.31

0.33

1.2

1.5

5.67

7.05

mmol/l

—

Allergic rhinitis

223

2328

0.95

0.33

1.4

6.63

6.86

mmol/l

0.48

161

1679

Other noninflammatory disorders of vagina

444

1.13

0.33

1.5

1.4

7.08

6.98

mmol/l

0.07

328

Persistent delusional disorders

284

1.16

0.33

1.4

1.3

8.23

7.24

mmol/l

1.04

214

Acute appendicitis, with complications

1042

0.92

0.33

1.1

1.3

7.56

7.32

mmol/l

0.35

779

Adenomyosis (Endometriosis of uterus)

663

1.10

0.33

1.3

1.4

7.03

7.21

mmol/l

0.26

490

Other abnormal findings of blood chemistry

173

1.22

0.33

1.4

8.37

7.49

mmol/l

0.65

127

Malignant neoplasm of prostate

131

888

0.93

0.33

1.2

1.1

7.33

7.91

mmol/l

1.14

620

Other and unspecified injuries of lower leg

369

1.14

0.32

1.4

6.97

7.09

mmol/l

0.12

264

Noninfectious colitis NAS

645

0.90

0.32

1.3

7.62

7.11

mmol/l

0.51

476

Ventral hernia

116

1077

1.08

0.32

1.4

1.2

7.54

7.55

mmol/l

0.02

776

Dyspnoea

557

4407

0.97

0.32

1.3

7.30

7.16

mmol/l

0.44

381

3194

Localized skin eruption due to drugs and medicaments

1.28

0.32

1.0

1.4

6.84

7.28

mmol/l

—

Pedestrian injured in other and unspecified transport accidents

1.28

0.32

1.2

1.3

6.10

7.60

mmol/l

—

Injuries to the wrist and hand

716

5339

0.97

0.32

1.3

1.4

7.10

7.02

mmol/l

0.28

542

3798

Gout, strict definition

559

1.11

0.32

1.1

1.2

8.37

7.89

mmol/l

0.56

394

Childhood allergy (age < 16)

155

1198

1.07

0.32

1.8

1.6

6.13

6.24

mmol/l

0.32

116

801

Atopic dermatitis, strict definition with reimbursement

264

2441

1.05

0.32

1.5

1.4

6.75

6.67

mmol/l

0.21

195

1766

Abnormal involuntary movements

588

1.11

0.32

1.2

1.3

7.01

7.28

mmol/l

0.27

436

Adverse effects, not elsewhere classified

133

1243

1.07

0.32

1.3

1.4

7.16

6.98

mmol/l

0.24

904

L04AC Interleukin inhibitors

241

0.83

0.31

1.3

6.65

7.19

mmol/l

0.22

171

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

333

3127

1.04

0.31

1.3

7.21

7.24

mmol/l

0.05

240

2261

Inflammatory diseases of female pelvic organs

514

3746

1.03

0.31

1.4

6.96

6.83

mmol/l

0.53

383

2666

Other disorders of patella

125

1167

1.07

0.31

1.3

6.89

7.17

mmol/l

0.57

869

Shoulder region

1.33

0.31

1.4

1.3

6.22

7.59

mmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

326

0.86

0.31

1.4

1.3

9.07

7.39

mmol/l

1.40

241

Aortic valve malfunction, age under 60 years

432

0.88

0.31

1.2

7.33

7.38

mmol/l

0.03

320

Atopic dermatitis

471

3883

1.04

0.30

1.5

1.4

6.54

6.88

mmol/l

2.06

346

2824

Dislocation, sprain and strain of joints and ligaments of head

229

0.83

0.30

1.3

1.4

5.93

7.04

mmol/l

1.01

155

ILD, hospital admissions 1, main diag only

428

1.12

0.30

1.2

7.23

7.67

mmol/l

0.48

306

Ulcerative colitis, NAS

767

0.91

0.30

1.4

7.27

7.08

mmol/l

0.20

561

Carcinoma in situ of skin

229

0.83

0.30

1.2

8.51

7.95

mmol/l

0.28

147

Undetermined asthma, excluding more controls

647

1.10

0.30

1.3

7.52

7.07

mmol/l

0.56

460

Asthma-related pneumonia or sepsis

158

1674

0.94

0.30

1.3

7.32

7.34

mmol/l

0.03

120

1189

Asthma, hospital admissions 3, pneumonia

158

1674

0.94

0.30

1.3

7.32

7.34

mmol/l

0.03

120

1189

Dislocation, sprain and strain of joints and ligaments of thorax

129

1.24

0.30

1.1

1.4

9.14

7.26

mmol/l

1.01

Benign neoplasm: Transverse colon

357

0.87

0.30

1.2

8.34

7.61

mmol/l

0.43

260

Subarachnoid haemorrhage

357

0.87

0.30

1.2

7.35

7.55

mmol/l

0.12

254

Dental pulpitis 3, only avohilmo

116

789

1.07

0.30

1.8

1.7

6.21

6.11

mmol/l

0.22

537

ILD, hospital admissions 3, with pneumonia sepsis

250

0.84

0.30

1.2

7.51

7.66

mmol/l

0.08

176

Cellulitis

103

1108

0.93

0.29

1.3

7.61

7.20

mmol/l

0.53

801

Retinal detachments and breaks

158

1490

1.06

0.29

1.1

1.2

7.43

7.68

mmol/l

0.38

103

1079

Endometriosis ASRM stages 3,4

146

1551

0.94

0.29

1.3

1.4

7.07

7.01

mmol/l

0.09

100

1110

Hypertrophy of breast

115

1073

1.07

0.29

1.3

1.4

7.07

7.11

mmol/l

0.06

783

Other disorders of ear

592

3827

1.03

0.29

1.2

1.3

7.59

7.20

mmol/l

1.85

424

2782

Calcific aortic valvular stenosis, including rheumatic fever

840

0.92

0.29

1.1

1.2

8.45

7.93

mmol/l

0.50

570

Pedal cyclist injured in other and unspecified transport accidents

546

0.90

0.29

1.4

6.82

7.05

mmol/l

0.18

401

Used for control exclusion in common control thyroid runs

896

4431

1.03

0.29

1.4

7.26

6.95

mmol/l

1.89

655

3156

Abrasion of teeth

204

1424

1.05

0.29

1.3

1.4

6.89

6.99

mmol/l

0.17

155

976

Other abnormal uterine and vaginal bleeding

142

951

1.07

0.29

1.3

1.4

7.74

7.08

mmol/l

1.48

106

686

DVT of lower extremities

786

0.92

0.29

1.4

1.2

7.34

7.57

mmol/l

0.24

573

Benign neoplasm of other and unspecified endocrine glands

563

1.10

0.29

1.3

7.66

7.41

mmol/l

0.26

413

Sequelae of other and unspecified infectious and parasitic diseases

260

0.84

0.29

1.4

1.3

6.90

7.36

mmol/l

0.22

195

Diplopia

556

0.90

0.29

1.4

1.3

8.27

7.26

mmol/l

0.85

406

Degeneration of macula and posterior pole

149

1304

0.94

0.29

1.2

7.59

7.85

mmol/l

0.41

109

904

Anomalies of dental arch relationship, including avohilmo

120

1151

0.94

0.29

1.4

6.38

6.92

mmol/l

1.65

831

HSIL lesion of the cervix uteri

151

1600

0.94

0.28

1.5

7.06

6.64

mmol/l

0.69

114

1149

Occupational exposure to risk-factors

130

1.23

0.28

1.5

1.3

6.48

7.48

mmol/l

0.77

Haemangioma and lymphangioma, any site

421

1.12

0.28

1.6

1.3

7.51

7.36

mmol/l

0.10

314

Asthma-related pneumonia

158

1669

0.94

0.28

1.3

7.32

7.35

mmol/l

0.04

120

1186

Other congenital malformations

497

1.11

0.28

1.8

1.5

7.22

6.91

mmol/l

0.31

344

Other congenital malformations of skin

195

1.18

0.28

1.9

1.4

7.20

7.19

mmol/l

0.00

132

Other and unspecified disorders of skin and subcutaneous tissue

259

0.85

0.28

1.1

1.3

7.18

7.27

mmol/l

0.07

187

Injury of unspecified body region

317

1.14

0.28

1.1

1.3

7.32

7.27

mmol/l

0.04

229

Crohn disease (strict definition, require KELA)

344

0.87

0.28

1.5

1.4

7.62

6.89

mmol/l

0.53

245

Other pulmonary heart/vessel disease

129

0.77

0.28

1.3

6.58

7.09

mmol/l

—

Chronic suppurative otitis media, including avohilmo

336

1.13

0.28

1.2

1.4

6.74

7.14

mmol/l

0.52

242

Other gastritis (incl. Duodenitis)

109

1018

1.07

0.28

1.3

1.2

7.35

7.55

mmol/l

0.28

740

Acute lymphadenitis

308

1.14

0.28

1.4

7.46

6.95

mmol/l

0.30

229

Other arrhythmias

441

3267

1.03

0.27

1.2

1.3

7.04

7.15

mmol/l

0.34

339

2357

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

575

1.10

0.27

1.2

1.3

8.11

7.65

mmol/l

0.41

411

Ptosis of eyelid

384

1.12

0.27

1.3

6.96

7.58

mmol/l

0.71

273

Other disorders of nervous system

233

1.16

0.27

1.4

1.3

7.21

7.43

mmol/l

0.14

171

Post-traumatic stress disorder

720

0.92

0.27

1.5

7.62

6.60

mmol/l

1.70

508

Disorders of parathyroid gland

752

0.92

0.27

1.2

7.87

7.61

mmol/l

0.23

537

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

318

1.13

0.27

1.2

1.3

6.60

7.37

mmol/l

0.95

234

Medical treatment for female infertility

205

1950

1.05

0.27

1.5

6.75

6.64

mmol/l

0.20

137

1403

Iron deficiency anaemia secondary to blood loss (chronic)

614

1.09

0.27

1.2

1.3

7.46

7.55

mmol/l

0.07

442

Sequelae with surgical and medical care as external cause

855

1.08

0.27

1.4

1.3

7.54

7.43

mmol/l

0.12

623

Malignant neoplasm of urinary organs

311

0.87

0.27

1.4

1.2

7.36

7.65

mmol/l

0.20

227

Residual foreign body in soft tissue

224

1.16

0.27

1.3

6.78

7.39

mmol/l

0.59

161

Pneumothorax

247

0.85

0.27

1.2

1.3

7.14

7.50

mmol/l

0.36

178

Polymyalgia rheumatica

385

1.12

0.26

1.3

1.2

8.09

7.77

mmol/l

0.24

268

ILD, hospital admissions

471

1.10

0.26

1.2

7.29

7.65

mmol/l

0.35

338

Undetermined asthma

653

1.09

0.26

1.3

7.52

7.03

mmol/l

0.63

465

Monoarthritis, not elsewhere classified

182

0.82

0.26

1.1

1.4

5.35

7.36

mmol/l

—

132

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

376

1.12

0.26

1.1

1.3

7.66

7.57

mmol/l

0.07

275

Pterygium

1.27

0.26

1.3

6.46

7.34

mmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

818

1.08

0.26

1.3

1.2

7.75

7.71

mmol/l

0.04

592

Adenocarcinoma and papillary adenocarcinoma of stomach

0.69

0.26

1.4

1.2

7.10

7.77

mmol/l

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.68

0.26

1.0

1.2

8.10

7.74

mmol/l

—

Malignant melanoma

541

0.90

0.26

1.2

1.3

7.12

7.57

mmol/l

0.56

395

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.68

0.26

1.4

1.2

7.10

7.92

mmol/l

—

Other diseases of anus and rectum

146

1380

1.06

0.26

1.2

1.3

7.43

7.59

mmol/l

0.26

105

976

Vasomotor and allergic rhinitis

293

2779

1.04

0.26

1.4

6.84

6.94

mmol/l

0.19

218

2005

Benign neoplasm of middle ear and respiratory system

310

1.13

0.26

1.3

7.96

7.60

mmol/l

0.23

227

Emotional disorders starting during childhood or adolecense, excluding more controls

378

1.12

0.26

1.7

7.61

6.34

mmol/l

1.04

259

Gout

834

1.07

0.26

1.2

8.27

7.72

mmol/l

0.89

583

Mandibular retrognathia

366

1.12

0.25

1.3

1.4

6.16

6.87

mmol/l

0.99

259

malignant neoplasm of male genital organs

138

928

0.94

0.25

1.2

1.1

7.44

7.87

mmol/l

0.73

650

Paralytic strabismus

235

0.85

0.25

1.3

7.92

7.34

mmol/l

0.24

168

Congenital malformations and deformations of the musculoskeletal system

508

1.10

0.25

1.4

1.5

6.76

6.87

mmol/l

0.11

363

Cutaneous abscess, furuncle and carbuncle

157

1490

1.05

0.25

1.5

1.3

7.01

7.08

mmol/l

0.12

118

1094

Dislocation, sprain and strain of joints and ligaments at neck level

109

1023

1.07

0.25

1.5

1.4

6.72

6.88

mmol/l

0.29

743

Neuromuscular dysfunction of bladder

377

1.12

0.25

1.4

1.3

7.96

7.49

mmol/l

0.48

277

Constipation

530

3691

1.03

0.25

1.3

7.46

7.25

mmol/l

0.73

410

2650

Excessive, frequent and irregular menstruation

390

2099

1.03

0.25

1.4

1.5

6.97

6.66

mmol/l

1.38

279

1492

ILD, hospital admission 2, with pulmonary infections

298

0.87

0.25

1.2

7.51

7.59

mmol/l

0.05

202

Complications of medical and surgical care

430

4206

0.97

0.25

1.3

7.42

7.19

mmol/l

0.67

296

3039

Congenital malformations, deformations and chromosomal abnormalities

440

4341

0.97

0.25

1.4

7.15

6.92

mmol/l

0.87

323

3117

Benign neoplasm: Stomach

330

1.12

0.25

1.3

7.56

7.72

mmol/l

0.12

236

Exposure to other and unspecified inanimate mechanical forces

319

0.88

0.25

1.7

1.3

7.15

7.18

mmol/l

0.01

234

Nonischemic cardiomyopathy

202

0.84

0.24

1.1

1.2

8.14

7.21

mmol/l

0.50

151

Benign neoplasm of thyroid gland

142

1.20

0.24

1.1

1.4

6.60

7.64

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

245

1.14

0.24

1.1

1.3

7.10

7.42

mmol/l

0.17

179

Ectopic pregnancy

122

1151

1.06

0.24

1.6

1.3

7.02

7.06

mmol/l

0.05

849

Benign neoplasm: Colon

243

1787

1.04

0.24

1.2

7.40

7.53

mmol/l

0.24

178

1275

Valvular operations

497

0.90

0.24

1.1

1.2

8.09

7.68

mmol/l

0.26

347

Coxibs

216

1100

1.05

0.24

1.2

1.4

7.28

6.89

mmol/l

0.92

167

725

Disorders of eyelid, lacrimal system and orbit

543

4147

1.03

0.24

1.3

7.18

7.20

mmol/l

0.04

398

2988

Prurigo nodularis

0.73

0.24

1.2

1.3

6.94

7.50

mmol/l

—

Elevated blood glucose level

350

1.12

0.24

1.4

1.3

7.96

7.23

mmol/l

0.96

258

Scleritis and episcleritis

293

1.13

0.24

1.5

1.3

6.38

7.19

mmol/l

1.14

209

Glaucoma, exfoliation

293

1.13

0.24

1.2

7.79

8.07

mmol/l

0.23

188

Benign neoplasm: Sigmoid colon

693

0.92

0.23

1.1

1.2

6.41

7.75

mmol/l

2.89

486

Burns and corrosions

724

0.92

0.23

1.4

1.3

6.43

7.07

mmol/l

1.12

531

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

341

1.12

0.23

1.1

1.3

7.77

7.58

mmol/l

0.17

256

Benign neoplasm of mouth and pharynx

475

1.10

0.23

1.3

8.00

7.44

mmol/l

0.50

351

Accidents

759

3717

1.02

0.23

1.4

7.17

7.01

mmol/l

0.66

556

2639

Vestibular neuronitis

341

1.12

0.23

1.3

6.96

7.37

mmol/l

0.37

256

Somnolence, stupor and coma

158

0.82

0.23

1.2

1.4

7.11

7.30

mmol/l

—

113

Interstitial lung disease

475

1.10

0.23

1.2

7.29

7.65

mmol/l

0.35

340

Interstitial lung disease endpoints

475

1.10

0.23

1.2

7.29

7.65

mmol/l

0.35

340

Other specified/unspecified systemic involvement of connective tissue

254

0.86

0.23

1.2

1.3

7.06

7.38

mmol/l

0.23

182

Non-selective monoamine reuptake inhibitors

212

1972

1.04

0.23

1.3

7.44

7.41

mmol/l

0.04

152

1441

Unspecified acute lower respiratory infection

726

1.08

0.23

1.3

7.69

7.20

mmol/l

0.68

535

Suppurative and unspecified otitis media

283

2599

0.96

0.23

1.5

6.86

6.70

mmol/l

0.33

214

1845

Other and unspecified injuries of head

237

1.14

0.23

1.1

1.3

7.05

7.29

mmol/l

0.16

173

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

243

0.86

0.23

1.2

1.3

8.20

7.82

mmol/l

0.13

170

Thrombocytopenia, unspecified

243

0.86

0.23

1.6

1.3

7.95

7.41

mmol/l

0.23

173

All influenza

123

1299

0.95

0.23

1.4

1.3

7.14

7.24

mmol/l

0.12

941

Toxic effects of substances chiefly nonmedicinal as to source

601

1.08

0.23

1.3

1.4

7.11

6.91

mmol/l

0.22

433

Unspecified haematuria

167

1499

0.95

0.23

1.2

7.82

7.60

mmol/l

0.37

123

1050

Erythema nodosum

134

1.20

0.23

1.2

1.4

7.84

7.29

mmol/l

—

Melanocytic naevi of lower limb, including hip

209

1.15

0.23

1.3

1.4

6.20

7.42

mmol/l

1.07

146

Otitis externa, unspecified

546

0.91

0.22

1.5

1.4

7.80

7.07

mmol/l

0.63

398

Congenital malformations of anterior segment of eye

1.25

0.22

1.0

1.5

7.00

6.82

mmol/l

—

Wet age-related macular degeneration

411

1.10

0.22

1.2

8.38

8.03

mmol/l

0.28

257

Urethritis and urethral syndrome

0.75

0.22

1.1

1.4

7.21

7.14

mmol/l

—

Psoriatic and enteropathic arthropathies

608

0.92

0.22

1.4

1.3

8.45

7.40

mmol/l

1.12

455

Major coronary heart disease event excluding revascularizations

300

2001

1.03

0.22

1.2

7.88

7.56

mmol/l

0.85

214

1438

Other interstitial pulmonary diseases

477

1.09

0.22

1.2

7.29

7.67

mmol/l

0.38

341

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

347

0.89

0.22

1.4

1.2

7.33

7.80

mmol/l

0.39

244

Abnormal findings on diagnostic imaging of central nervous system

210

1.14

0.21

1.3

1.4

6.44

7.36

mmol/l

0.68

146

Epidermolysis bullosa

0.00

0.21

0.0

1.5

—

7.78

—

Assault by drugs, medicaments and biological substances

0.00

0.21

0.0

1.4

—

6.82

—

Crohn's disease (strict) with PSC

0.00

0.21

0.0

1.4

—

7.14

—

Uterine polyps

420

1.10

0.21

1.3

6.78

7.42

mmol/l

1.04

315

Benign neoplasm: Cranial nerves

107

1.22

0.21

1.1

1.3

6.15

7.79

mmol/l

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.21

0.0

1.1

—

9.64

—

Benign neoplasm: Carotid body

0.00

0.21

0.0

1.1

—

8.70

—

Overexertion and strenuous or repetitive movements

482

0.91

0.21

1.1

1.3

7.18

7.16

mmol/l

0.01

355

Acute appendicitis, no complications

417

4047

1.03

0.21

1.4

1.3

7.07

7.03

mmol/l

0.08

311

2942

Early onset COPD, excluding more controls

946

0.94

0.21

1.4

1.2

7.71

7.36

mmol/l

0.44

682

GASTRO-related operations

786

3864

1.02

0.21

1.4

7.04

6.89

mmol/l

0.67

567

2748

Any gastric operation

786

3864

1.02

0.21

1.4

7.04

6.89

mmol/l

0.67

567

2748

Assault by other and unspecified firearm discharge

0.00

0.21

0.0

1.1

—

8.86

—

Dysphagia

113

1070

1.06

0.21

1.2

1.3

7.36

7.52

mmol/l

0.21

782

Telogen effluvium

0.00

0.21

0.0

1.5

—

7.41

—

Myocardial infarction, without ST-elevation

141

1239

1.05

0.21

1.2

8.23

7.85

mmol/l

0.70

860

Disorders of sexual preference

0.00

0.21

0.0

1.2

—

8.30

—

Other congenital malformations of digestive system

0.00

0.21

0.0

1.2

—

7.56

—

Injury of blood vessels at hip and thigh level

0.00

0.21

0.0

1.1

—

8.28

—

Malignant neoplasm of penis

0.00

0.21

0.0

1.0

—

7.83

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.21

0.0

1.1

—

7.50

—

Other coagulation defects

363

1.10

0.21

1.4

6.89

7.31

mmol/l

0.32

261

Benign neoplasm: Transverse colon

346

0.90

0.21

1.2

8.34

7.79

mmol/l

0.30

246

Syncope and collapse

237

2177

0.96

0.21

1.3

7.15

7.29

mmol/l

0.27

174

1513

Other and unspecified polyneuropathies, also in other diseases

678

0.93

0.21

1.4

1.2

7.45

7.74

mmol/l

0.30

486

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.2

—

7.75

—

Anaemias

211

1349

1.04

0.21

1.4

6.70

6.22

mmol/l

1.77

154

945

Type 1 diabetes, strict definition, subgroup 2

0.00

0.21

0.0

1.5

—

6.67

—

Osteomyelitis of vertebra

0.00

0.21

0.0

1.2

—

7.62

—

Rheumatic fever without mention of heart involvement

0.00

0.21

0.0

1.2

—

7.82

—

Listeriosis

0.00

0.21

0.0

1.3

—

7.93

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.0

—

9.57

—

Convergent concomitant strabismus

335

0.89

0.21

1.3

1.4

7.18

6.81

mmol/l

0.33

241

Oral leukoplakia and related diseases, including avohilmo

335

0.89

0.21

1.2

1.3

7.45

7.49

mmol/l

0.04

245

Other disorders of adrenal gland

198

0.86

0.20

1.0

1.4

6.10

7.36

mmol/l

2.26

142

Correction of physiology of bite - demanding therapy visit

412

1.09

0.20

1.4

6.38

7.06

mmol/l

1.47

296

Hypertensive heart and/or renal disease

637

0.94

0.20

1.2

7.70

7.60

mmol/l

0.11

437

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS